US20240000353A1 - Blood glucose management - Google Patents
Blood glucose management Download PDFInfo
- Publication number
- US20240000353A1 US20240000353A1 US18/470,167 US202318470167A US2024000353A1 US 20240000353 A1 US20240000353 A1 US 20240000353A1 US 202318470167 A US202318470167 A US 202318470167A US 2024000353 A1 US2024000353 A1 US 2024000353A1
- Authority
- US
- United States
- Prior art keywords
- lancet
- cover
- module
- strip
- biological
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008280 blood Substances 0.000 title abstract description 33
- 210000004369 blood Anatomy 0.000 title abstract description 33
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title abstract description 26
- 239000008103 glucose Substances 0.000 title abstract description 26
- 230000000994 depressogenic effect Effects 0.000 claims abstract description 29
- 230000002093 peripheral effect Effects 0.000 claims description 38
- 238000012360 testing method Methods 0.000 abstract description 48
- 239000012472 biological sample Substances 0.000 abstract description 38
- 238000000034 method Methods 0.000 abstract description 9
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 30
- 239000000463 material Substances 0.000 description 23
- 102000004877 Insulin Human genes 0.000 description 15
- 108090001061 Insulin Proteins 0.000 description 15
- 229940125396 insulin Drugs 0.000 description 15
- 230000004044 response Effects 0.000 description 14
- 230000036407 pain Effects 0.000 description 10
- 238000000576 coating method Methods 0.000 description 7
- 239000000853 adhesive Substances 0.000 description 6
- 230000001070 adhesive effect Effects 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 230000000007 visual effect Effects 0.000 description 5
- 239000013060 biological fluid Substances 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000037324 pain perception Effects 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 238000003754 machining Methods 0.000 description 3
- 238000007726 management method Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 238000003149 assay kit Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000002313 adhesive film Substances 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000009189 diving Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002310 elbow joint Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000011542 limb amputation Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000037325 pain tolerance Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150534—Design of protective means for piercing elements for preventing accidental needle sticks, e.g. shields, caps, protectors, axially extensible sleeves, pivotable protective sleeves
- A61B5/150572—Pierceable protectors, e.g. shields, caps, sleeves or films, e.g. for hygienic purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/14—Devices for taking samples of blood ; Measuring characteristics of blood in vivo, e.g. gas concentration within the blood, pH-value of blood
- A61B5/1405—Devices for taking blood samples
- A61B5/1411—Devices for taking blood samples by percutaneous method, e.g. by lancet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150015—Source of blood
- A61B5/150022—Source of blood for capillary blood or interstitial fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
- A61B5/150267—Modular design or construction, i.e. subunits are assembled separately before being joined together or the device comprises interchangeable or detachable modules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150358—Strips for collecting blood, e.g. absorbent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150412—Pointed piercing elements, e.g. needles, lancets for piercing the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150847—Communication to or from blood sampling device
- A61B5/150862—Communication to or from blood sampling device intermediate range, e.g. within room or building
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150847—Communication to or from blood sampling device
- A61B5/15087—Communication to or from blood sampling device short range, e.g. between console and disposable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150885—Preventing re-use
- A61B5/150893—Preventing re-use by indicating if used, tampered with, unsterile or defective
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150969—Low-profile devices which resemble patches or plasters, e.g. also allowing collection of blood samples for testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15101—Details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15101—Details
- A61B5/15103—Piercing procedure
- A61B5/15105—Purely manual piercing, i.e. the user pierces the skin without the assistance of any driving means or driving devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15142—Devices intended for single use, i.e. disposable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15146—Devices loaded with multiple lancets simultaneously, e.g. for serial firing without reloading, for example by use of stocking means.
- A61B5/15148—Constructional features of stocking means, e.g. strip, roll, disc, cartridge, belt or tube
- A61B5/15149—Arrangement of piercing elements relative to each other
- A61B5/15151—Each piercing element being stocked in a separate isolated compartment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15146—Devices loaded with multiple lancets simultaneously, e.g. for serial firing without reloading, for example by use of stocking means.
- A61B5/15148—Constructional features of stocking means, e.g. strip, roll, disc, cartridge, belt or tube
- A61B5/15157—Geometry of stocking means or arrangement of piercing elements therein
- A61B5/15159—Piercing elements stocked in or on a disc
- A61B5/15163—Characterized by propelling the piercing element in an axial direction relative to the disc
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/157—Devices characterised by integrated means for measuring characteristics of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/7405—Details of notification to user or communication with user or patient ; user input means using sound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/7455—Details of notification to user or communication with user or patient ; user input means characterised by tactile indication, e.g. vibration or electrical stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/04—Constructional details of apparatus
- A61B2560/0443—Modular apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0295—Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150175—Adjustment of penetration depth
- A61B5/15019—Depth adjustment mechanism using movable stops located inside the piercing device housing and limiting the travel of the drive mechanism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
- A61B5/150213—Venting means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150503—Single-ended needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150534—Design of protective means for piercing elements for preventing accidental needle sticks, e.g. shields, caps, protectors, axially extensible sleeves, pivotable protective sleeves
- A61B5/150633—Protective sleeves which are axially extensible, e.g. sleeves connected to, or integrated in, the piercing or driving device; pivotable protective sleeves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150534—Design of protective means for piercing elements for preventing accidental needle sticks, e.g. shields, caps, protectors, axially extensible sleeves, pivotable protective sleeves
- A61B5/150664—Pivotable protective sleeves, i.e. sleeves connected to, or integrated in, the piercing or driving device, and which are pivoted for covering or uncovering the piercing element
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15142—Devices intended for single use, i.e. disposable
- A61B5/15144—Devices intended for single use, i.e. disposable comprising driving means, e.g. a spring, for retracting the piercing unit into the housing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
- A61B5/7445—Display arrangements, e.g. multiple display units
Definitions
- This disclosure relates to technology for collecting biological samples to measure a biological property.
- Devices for managing blood glucose typically include a lancing tool.
- the tool In operation, the tool is opened, and a disposable lancet can be uncovered and inserted into the tool.
- the user can position the tip against his or her finger and actuate the tool. After that, the blood sample can be transported to a glucose measuring device for analysis.
- standard practice is for the user to re-open the tool, and remove and dispose of the lancet.
- the devices may offer additional features such as a means for the user to enter a depth of insertion of the tool via a dial or a similar input mechanism.
- Blood flow and pain while lancing can be adjusted by the depth of insertion of the lancet.
- a lancet that is inserted deeper than levels recommended for a specific user can cause a high volume of blood flow and significant pain.
- a lancet that is inserted less deep than recommended levels introduces less pain, but does not draw sufficient quantity of blood for testing blood glucose levels.
- the lancet can also be replaced with each use to prevent risk of infection. Replacing a lancet with each use can also prevent the lancet from becoming duller with use, and consequently provide less pain while lancing. Pain, expense, and user-unfriendliness are common reasons why diabetes patients may be less likely to monitor their blood glucose levels with diligence.
- a lancet device can include a base that includes a support surface, a lancet and a cover.
- the cover can include a peripheral edge along which the cover is connected to the base, a cover region, a lancet aperture, and a peripheral hinge near the peripheral edge.
- the cover region can cover the lancet when the cover is in an un-depressed position.
- the lancet can be configured to protrude through the lancet aperture when the cover is in a depressed position.
- the peripheral hinge can facilitate controlled movement of the cover from the un-depressed position to the depressed position upon application of a predetermined depression force.
- a method of collecting a biological sample may include providing a lancet device such as that discussed above.
- a predetermined force can be applied on the cover region.
- the cover can move from an un-depressed position in which the cover region covers the lancet to a depressed position in which the lancet protrudes through the lancet aperture and exposes biological fluid.
- a quantity of the biological fluid as the biological sample can be collected.
- the lancet device can be easy to use because it eliminates assembly of multiple pieces.
- the lancet device can controllably move the skin surface onto and off of a lancet to minimize pain and maximize blood flow.
- different lancet devices can be offered for users with different anatomical features—e.g., one lancet device for users with relatively thick finger skin, and another lancet device for users with relatively thin finger skin.
- Some embodiments with multiple lancet stations provide visual evidence of which lancet stations have been used and which ones have not yet been used. Some embodiments prevent a lancet station from being used more than once.
- Some embodiments provide feedback (e.g., audible and/or tactile) as lancing occurs to increase patient comfort.
- the lancet device can provide increased compliance because of its small size, portability and less pain during use, fewer complications during collection of the biological sample and decreased total cost.
- the biological test kit can include a reusable module and a disposable module.
- the disposable module can include one or more lancet devices, such as those described elsewhere herein, and one or more strip stations.
- the strip station can support one or more biological test strips that can interact with the collected biological sample.
- the reusable module can support measuring equipment that can measure a property of the biological sample.
- a reusable module connector and a disposable module connector may removably connect the reusable module and the disposable module.
- a display monitor can be included with the reusable module to display the measured property.
- the biological test kit can offer ease of use and portability.
- different components can be replaced at different intervals.
- the disposable module may be replaced with each use (or after a relatively small number of uses), while the reusable module may be replaced at significantly longer intervals.
- the disposable module is made up of a lancet station module and a strip station module
- the lancet station module and the strip station module can be replaced at different intervals.
- Multiple lancing events can be performed with the same device, enabling a user to monitor blood glucose levels at a recommended interval.
- the biological test kit can enable one finger operation.
- the entire biological test kit can be roughly the size of a credit card, which can make it more accessible, portable, increase testing compliance and enable a connected real-time management of glucose.
- FIG. 1 is a front elevation view of a lancet device according to embodiments of the invention with the cover in an un-depressed position.
- FIG. 2 is a front elevation view of the lancet device of FIG. 1 with the cover in a depressed position.
- FIG. 3 is a front elevation view of a lancet device according to embodiments of the invention with the cover in the depressed position.
- FIG. 4 ( a ) is a front elevation view of a lancet device according to embodiments of the invention with the cover in the un-depressed position.
- FIG. 4 ( b ) is a top plan view of a lancet device of FIG. 4 ( a ) .
- FIG. 5 ( a ) is a front elevation view of a lancet device according to embodiments of the invention with the cover in the un-depressed position.
- FIG. 5 ( b ) is a top plan view of the lancet device of FIG. 5 ( a ) .
- FIG. 6 is a graph that shows the force applied to the lancet cover at various stages of use of a lancet device.
- FIG. 7 is a front elevation view of a lancet device according to embodiments of the invention with the cover in the un-depressed position.
- FIG. 8 is a top plan view of a lancet device according to embodiments of the invention.
- FIG. 9 ( a ) is a front elevation view of a lancet device according to embodiments of the invention with the cover in the un-depressed position, and a cap in a capped position.
- FIG. 9 ( b ) is a top plan view of the lancet device of FIG. 9 ( a ) with the cap in the capped position.
- FIG. 10 ( a ) is a top plan view of a biological test kit according to embodiments of the invention.
- FIG. 10 ( b ) is a front elevation view of the biological test kit of FIG. 10 ( a ) .
- FIG. 11 is an exploded front elevation view of a biological test kit according to embodiments of the invention.
- FIG. 12 is an exploded perspective view of a biological test kit according to embodiments of the invention.
- FIG. 13 is a perspective view of a biological test kit according to embodiments of the invention.
- FIG. 14 is a top plan view of a biological test kit according to embodiments of the invention.
- FIG. 15 is a top plan view of a biological test kit according to embodiments of the invention.
- FIG. 16 is a perspective view of a biological test kit according to embodiments of the invention.
- FIG. 17 is a perspective view of a biological test kit according to embodiments of the invention.
- Embodiments of the invention include a lancet device 100 to collect biological samples.
- the lancet device 100 can include a base 102 , a lancet 104 , and a cover 106 .
- the base 102 can include a support surface 108 .
- the base 102 can be made of a material that is rigid in comparison to the cover 106 .
- the base 102 can be made of materials such as a rigid polymer, metal, etc.
- the base 102 can be of any desired size or shape.
- the base 102 may be operably coupled to the cover 106 .
- the support surface 108 may be a generally planar surface that can house the lancet 104 .
- the support surface 108 in the illustrated embodiment is an upper surface of the base 102 .
- the support surface 108 can be made of similar materials as the base 102 and can be rigid in comparison to the cover 106 .
- the base 102 can support a lancet 104 , which can extend away from the support surface 108 at an angle of approximately 90°. In many embodiments, the lancet 104 can remain stationary with respect to the base 102 .
- the lancet 104 can include a lancing edge 150 adapted to make an incision or a puncture on a surface (e.g., skin).
- the lancet 104 can be made of materials such as stainless steel or similar alloys.
- the lancing edge 150 can be fabricated by grinding or a similar machining technique so that the lancing edge is of a specific geometry and sharpness to pierce a surface such as skin without causing the lancet 104 to break.
- the lancet 104 can be configured to pierce the skin of a user to collect a quantity of blood sample.
- the cover 106 can be operably coupled to the base 102 of the lancet device 100 .
- the cover 106 can include a peripheral edge 110 along which the cover is connected to the base.
- the cover 106 can be coupled to the base 102 at a selected location near the peripheral edge 110 .
- the cover 106 can be coupled to the base 102 along the entire peripheral edge 110 .
- the cover 106 can be made of a polymeric material that has a sufficiently large elasticity to move a specific distance when a specified force is applied on the cover.
- the polymeric or metallic material may be selected to include favorable elastic properties that allow the cover to move in a controlled manner.
- a spring, foam, cam and helix device, or other suitable mechanism can be included between the cover 106 and the base 102 that facilitates controlled movement of the cover when a predetermined depression force is applied.
- the cover 106 can include a cover region 120 configured to cover the lancet 104 when the cover 106 is in an un-depressed position.
- the cover region 120 has a hemispherical or domed shape in the un-depressed position in the illustrated embodiment.
- the height of the cover region above the base is indicated as “h”, and the diameter of the cover region in the un-depressed position is indicated as “d”.
- the cover region 120 can have any desired shape in the un-depressed position such as a cuboidal cover region with rounded edges or similar shapes.
- the cover 106 can include a diving board configuration.
- the cover region 120 can comprise a cover region geometry that includes cover region edges 122 and 124 .
- the cover region edges 122 and 124 define a cover region wall thickness “a”.
- the cover region 120 can move a specific distance when a predetermined depression force is applied on the cover region 120 .
- the predetermined depression force can cause the cover region 120 to move in a controlled manner from the un-depressed position, to a depressed position, shown in FIGS. 2 and 3 .
- the cover region 120 provides access to the lancet 104 .
- the cover 106 can include a peripheral hinge 116 near the peripheral edge 110 as shown in FIG. 4 ( a ) .
- the peripheral hinge 116 can include peripheral hinge geometry.
- the peripheral hinge geometry can comprise a variety of configurations.
- peripheral hinge edges 112 , 114 can define a peripheral hinge wall thickness “b” as shown in FIG. 4 ( a ) .
- the peripheral hinge geometry can include peripheral hinge edge 112 or peripheral hinge edge 114 but not both.
- the peripheral hinge geometry can include rounded or angular hinges.
- Peripheral hinge edges 112 , 114 can include or can be replaced by curved, angled or box-shaped notches or projections near the peripheral edge 110 .
- the notches can be angled as V or H-shaped notches with a projection of complementary shape.
- the notches or projections can act as a hinge joint and can resemble a knee or an elbow joint. It can be appreciated that other hinge shapes that introduce a similar effect can be included without any loss of functionality.
- the peripheral hinge 116 facilitates the controlled movement of the cover 106 from the un-depressed position to the depressed position upon application of a predetermined depression force.
- the peripheral hinge geometry can differ from the cover region geometry.
- the cover region thickness “a” can be different from the peripheral hinge thickness “b”.
- the peripheral hinge wall thickness “b” is between approximately 25% and approximately 50% of the cover region wall thickness “a”. In some embodiments, the peripheral hinge wall thickness “b” is less than half of the cover region wall thickness “a”. In some embodiments, the peripheral hinge wall thickness “b” is between 2 ⁇ 3 and 3 ⁇ 4 the cover region wall thickness “a”. In some embodiments, the peripheral hinge wall thickness “b” is less than 2 ⁇ 3 the cover region wall thickness “a”. In some embodiments, the peripheral hinge wall thickness “b” is less than 3 ⁇ 4 the cover region wall thickness “a”.
- the cover region thickness “a” and the peripheral wall hinge thickness “b” can be varied during fabrication of the device.
- the lancet device 100 can be configured such that the cover 106 moves from the un-depressed position to the depressed position upon application of a predetermined force that a typical user would be capable of applying.
- the predetermined depression force can be between approximately 500 and approximately 1500 grams. In some embodiments the predetermined depression force can be between approximately 700 grams and approximately 2000 grams. In some embodiments, the predetermined depression force can be between approximately 800 grams and approximately 1200 grams. In some embodiments, the predetermined depression force can be between approximately 700 grams and approximately 800 grams. In some embodiments, the predetermined depression force can be between approximately 800 grams and approximately 900 grams. In some embodiments, the predetermined depression force can be between approximately 900 grams and approximately 1000 grams.
- the predetermined depression force can be between approximately 1000 grams and approximately 1100 grams. In some embodiments, the predetermined depression force can be between approximately 1100 grams and approximately 1200 grams. In some embodiments, the predetermined depression force can be between approximately 1200 grams and approximately 1300 grams. In some embodiments, the predetermined depression force can be between approximately 1300 grams and approximately 1400 grams. In some embodiments, the predetermined depression force can be between approximately 1400 grams and approximately 1500 grams. In some embodiments, the predetermined depression force can be between approximately 1500 grams and approximately 1600 grams. In some embodiments, the predetermined depression force can be between approximately 1600 grams and approximately 1700 grams. In some embodiments, the predetermined depression force can be between approximately 1700 grams and approximately 1800 grams.
- the predetermined depression force can be between approximately 1800 grams and approximately 1900 grams. In some embodiments, the predetermined depression force can be between approximately 1900 grams and approximately 2000 grams. In some embodiments, the predetermined depression force can be greater than 2000 grams.
- the distance traveled by the cover region 120 between the un-depressed (shown as dashed lines in FIGS. 2 - 3 ) and the depressed position, is indicated by a depression depth “f” in FIGS. 2 - 3 .
- the depression depth “f” can be between approximately 0.2 millimeters and approximately 4 millimeters when the predetermined force is applied. Different configurations with different required depression forces may be offered for different kinds of users.
- the depression depth can be adjusted by including a design of the cover region 120 with a diameter “e” and a height “g” that are different from the illustrated diameter “d” and the illustrated height “h”.
- the cover 106 can include a lancet aperture 132 through which the lancet 104 is configured to protrude when the cover 106 is in a depressed position.
- the lancet aperture 132 is illustrated as a circular opening in FIG. 5 ( b ) , but can also be of other shapes.
- the diameter or the opening size of the lancet aperture 132 is at least equal to the thickness of the lancet as shown in FIG. 5 ( a ) so that the lancet 104 protrudes out of the lancet aperture 132 when the cover 106 is in the depressed position.
- the lancet aperture 132 may be introduced in the cover region 120 by cutting or tearing the cover region 120 appropriately to the required geometry and dimensions of the lancet aperture 132 .
- the lancet 104 can protrude through the lancet aperture 132 to a protrusion height “c” when the cover 106 is in the depressed position as shown in FIGS. 2 - 3 .
- the protrusion height “c” of the lancet 104 can be between approximately 0.3 millimeters and approximately 1.2 millimeters.
- the protrusion height “c” can be selected so that optimal quantity of biological sample is collected. For example, if the lancet device is used for collecting blood from a user by lancing the user's finger skin, an appropriate protrusion height “c” can ensure optimal quantity of blood is drawn from the user's finger and at the same time minimizing pain in the user due to lancing.
- Anatomical features such as thickness of the finger skin, pain tolerance, and blood flow through a user's blood vessels can be considered by a user in deciding on a suitable protrusion height of the lancet.
- a user can, for instance, apply less force on the cover region 120 of the lancet device 100 , causing the protrusion height “c” to be lower, than in the case if the user where to apply more force on the cover region 120 .
- the cover 106 can be configured to provide an auditory and/or tactile response as the cover 106 moves from the un-depressed position to the depressed position upon application of the predetermined depression force.
- the auditory and/or tactile response can facilitate lower pain perception by a user.
- the cover 106 is engineered from a material such that the material provides an auditory response when it moves from the un-depressed position to the depressed position.
- the auditory response can be a pleasing sound (e.g., a snapping sound) when the force due to the user's finger pressure on the cover 106 equals the predetermined depression force.
- the pleasing sound can cause the user to perceive lower pain due to lancing.
- the pleasing sound can be accompanied by a tactile response (e.g., a sensation that the cover 106 has snapped past a threshold point), which can cause lower pain perception.
- the tactile response can be provided with little or no auditory response.
- the lancet 104 does not vibrate during lancing leading to lower pain perception.
- the cover 106 can be configured to provide a force response. This force response is illustrated in FIG. 6 .
- the force response facilitates movement of the cover 106 from the depressed position back to the un-depressed position upon removal of the predetermined depression force.
- the cover 106 is made of materials that can be engineered to provide the force response.
- the force response can be used to facilitate lower pain perception by a user.
- the cover 106 can be configured such that when the force due to finger pressure equals the predetermined depression force ( FIG. 6 , Point 2), the design features of the cover 106 can move from resisting the depression force to acceleration in downward movement until it reaches a designed stop ( FIG. 6 , Point 3).
- the depression force can lift from the cover ( FIG. 6 , Point 4).
- the design features of the cover region 120 can create a spring-like response accelerating the cover 106 back up which pushes upward and lifting the skin off the lancet 104 ( FIG. 6 , Point 5). Finally the skin is lifted from the cover 106 so that no force is applied ( FIG. 6 , Point 6).
- the cover 106 can include a release aperture 134 to release trapped air that might impede controlled movement of the cover 106 .
- the release aperture 134 can be located near the peripheral edge 110 of the cover 106 .
- the release aperture 134 is illustrated as a circular opening in FIG. 5 ( b ) . It can be appreciated that the release aperture 134 can be of other geometrical shapes without loss of functionality.
- the release aperture 134 can be of a size on the order of the size of the lancet aperture 132 . Any trapped air near the peripheral edge 110 of the cover 106 can resist movement of the cover region 120 toward the depressed position when the predetermined force is applied.
- the release aperture 134 allows the trapped air near the peripheral edge 110 (the air cannot escape through the lancet aperture 132 because the lancet aperture 132 is essentially sealed by the user's skin) to escape through the release aperture 134 outwardly from the peripheral edge 110 , thereby facilitating controlled movement of the cover region 120 between the un-depressed and depressed positions.
- the cover 106 can include a spike 162 extending toward the base 102 .
- the spike can be of a material similar to the lancet 104 , or other suitable material.
- the lancet device 100 can include a cavity 164 on the base 102 under the cover 106 .
- the cavity 164 may include a cavity wall 166 that holds pressurized gas.
- the cavity 164 can release pressurized gas upon being pierced by the spike 162 .
- the released gas can exert pressure on the cover 106 to push the cover 106 from the depressed position back to the un-depressed position.
- the pressurized gas combination can be used in addition to the cover 106 with engineered materials capable of providing a force response.
- the base 102 can include a visual indicator 170 that shows if the cover has been moved from the un-depressed position to the depressed position as shown in FIG. 8 .
- the base 102 can be made of a material that can be configured to provide a pattern or a color change. The color or pattern change can occur when the applied force on the cover region 120 , such as due to finger pressure when lancing, exceeds the predetermined depression force.
- the visual indicator 170 can include a color or pattern changing surface made of materials such as pressure sensitive coating or films operably coupled to the base 102 .
- the visual indicator 170 facilitates a user in identifying whether a lancet device was previously used and allow for single use of a lancet device. Visual indicators other than those shown may be incorporated into lancet devices in various embodiments of the present invention.
- the base 102 can include a stop 180 under the cover 106 .
- the stop 180 can be configured to dictate a distance by which the lancet 104 is configured to protrude through the lancet aperture when the cover 106 is in the depressed position.
- the size of the stop 180 can be determined during manufacture based on the depth of insertion of the lancet 104 .
- the stop 180 is illustrated as a rectangular projection in FIG. 3 . It can be appreciated that the stop 180 can have any desired shape, such as a hemispherical projection or other shapes.
- the stop 180 can be fabricated from materials similar to the base 102 .
- the stop 180 can be included with the base 102 as a single component during fabrication.
- the lancet device can include a cap 140 as shown in FIGS. 9 ( a )- 9 ( b ) .
- the cap 140 can operably couple with the base 102 by a hinge connection 142 as shown in the illustrated embodiment, or by similar mechanical fasteners.
- the cap 140 can be made of materials similar to that of the base 102 .
- the cap 140 can be positioned from a capped position to an uncapped position. In the capped position, the cap 140 is in close proximity to the base 102 , and encloses the cover 106 , thereby preventing access to the lancet 104 . In the uncapped position, the cap 140 facilitates access to the lancet 104 .
- the cap 140 can be configured to act as a sterile barrier when in the capped position to isolate the lancet 104 from contaminants.
- a lancet device 100 such as those discussed elsewhere herein can be used for collecting blood from a user for monitoring glucose.
- the lancet device 100 can be used for collecting similar biological samples.
- a user can apply a force on the cover region 120 .
- the force applied by the user can be due to finger pressure.
- the force applied on the cover region 120 may increase as indicated by the force ramp during stages 1-2 in FIG. 6 .
- the cover 106 can move from an un-depressed position in which the cover region covers the lancet to a depressed position during stage 2-3 in FIG. 6 .
- the lancet 104 protrudes through the lancet aperture 132 in the depressed position and exposes biological fluid.
- a quantity of the biological fluid as the biological sample can be collected during stages 3-4 in FIG. 6 .
- the cover region 120 exerts a pushing force opposite to the force applied by the user.
- the pushing force can be as a result of tension in the cover region 120 due to its material elasticity and/or by one or more mechanical tensioning elements included in the cover region as discussed elsewhere herein.
- the pushing force from the cover region 120 gradually increases as shown by the force ramp during stages 4-5 in FIG. 6 .
- stage 5 the cover region 120 has moved from the depressed position back to the un-depressed position. The user can then remove the finger from the lancet device and proceed to provide the biological sample for the desired purpose.
- the biological test kit 200 can include a reusable module 210 and a disposable module 220 .
- the disposable module 220 and reusable module 210 can be fabricated as a single, integral module and cannot be modularly connected to and disconnected from one another.
- the disposable module 220 can be removably connected with the reusable module 210 .
- the biological test kit 200 is illustrated as having a rectangular shape in FIG. 7 , but can have any desired shape such as square or oval without loss of functionality. In the illustrated embodiment, the biological test kit has a length “x”, a width “y” and a thickness “z”.
- the thickness “z” of the biological test kit 200 can be substantially less than the length “x” or the width “y”.
- the biological test kit 200 can be fabricated by molding a rigid polymer material such as plastic or by machining a similar material. In some embodiments, the thickness “z” can be less than or equal to 1 ⁇ 2 inch. In some embodiments, the thickness “z” can be less than or equal to 0.35 inches. In some embodiments, the thickness “z” can be less than or equal to 0.2 inches.
- the reusable module 210 can include a reusable module housing 212 , measuring equipment 214 , and a reusable module connector 216 .
- the reusable module housing 212 can include a generally planar support surface to support the measuring equipment 214 .
- the reusable module housing 212 may include a second support surface.
- the second support surface can house the reusable module connector 216 .
- the planar support surface and the second support surface can be any of the surfaces of the reusable module 210 .
- the planar support surface supporting the measuring equipment 214 is the top surface of the reusable module housing 212 .
- the support surface that houses the reusable module connector 216 is a lateral surface of the reusable module housing 212 . Any of the top, bottom, front, back or lateral surfaces can house the measuring equipment 214 and reusable module connector 216 without loss of functionality of the biological test kit 200 .
- the measuring equipment 214 and the reusable module 210 connector can be supported by the reusable module housing 212 .
- the measuring equipment 214 can be configured to measure a property of a biological sample.
- the measuring equipment 214 can include a sensor that can measure a specific property of the biological sample by electro-chemical means or other methods known in the arts.
- the measuring equipment 214 can, for instance, be configured to measure blood glucose level. For example, a chemical reaction can occur between a specific quantity of blood glucose, and an enzyme or a reagent that generates an electric current at an electrode.
- the measuring equipment 214 can then be configured to sense the electric current and calibrated to correlate a specific value of an electric current to a blood glucose level.
- the reusable module 210 can include a display monitor 218 supported by the reusable module housing 212 and configured to display the measured property.
- the display monitor 218 can be a LCD panel or LED or similar display device that can display the measured property and/or other relevant information.
- the display monitor 218 can be supported by the reusable module housing 212 by any of the known methods, including microfabrication techniques.
- the display monitor 218 is a rectangular panel of diagonal length “w.” It may be appreciated that the display monitor 218 can be of any desired size or shape to display the measured property (e.g., as alphanumeric characters).
- the display monitor 218 for instance, can display blood glucose level as a numerical value in milligrams per deciliter, when the biological test kit 200 collects blood from users for diabetes management.
- the disposable module 220 can include a disposable module housing 222 , at least one lancet station, at least one strip station, and a disposable module connector 226 .
- the disposable module housing 222 can be made of a rigid polymer material such as plastic.
- the disposable module housing 222 may include a support surface to house at least one lancet station and one strip station, and can be adapted to provide support to multiple lancet and strip stations or other components.
- the disposable module housing 222 can include a second support surface that house the disposable module connector 226 .
- the first lancet station 240 can be supported by and is stationary relative to the disposable module housing 222 .
- the first lancet station 240 is illustrated in the embodiment as comprising a circular station, though other configurations are contemplated as within the scope of this disclosure.
- the first lancet station 240 can include a device such as the lancet device 100 described elsewhere herein.
- the first lancet station 240 can comprise a cover supported by the disposable module housing 222 .
- the cover can be fabricated from a polymeric material with sufficient elasticity to depress to a specific height upon application of a predetermined force.
- the cover can include an aperture that provides access to a lancet.
- the lancet can be supported by the disposable module housing.
- the first lancet station 240 can include any of the embodiments of the lancet device 100 .
- the first lancet station 240 can facilitate the generation of a first biological sample.
- the first biological sample for instance, can be a small quantity of blood for monitoring blood glucose.
- the first strip station 250 can be supported by the disposable module housing 222 .
- the first strip station 250 can include a first biological strip 260 configured to receive the first biological sample.
- the first biological strip 260 can be rectangular with a thickness much smaller than length and width.
- the first biological strip 260 can be fabricated from a sheet of polymeric material with coatings to generate a signal that can be input to the measuring equipment 214 when exposed to the first biological sample.
- the first biological strip 260 can include a coating of an enzyme or a reagent that can electro-chemically react with the first biological sample.
- the first strip station 250 can be configured to provide the first biological sample to the measuring equipment 214 for measurement of the property.
- the disposable module connector 226 can be supported by the disposable module housing 222 and can be modularly connectible to the reusable module connector 216 .
- the disposable module connector 226 and the reusable module connector 216 can together comprise an interlocking fastener.
- the disposable and reusable module connectors 226 and 216 can be mechanical connectors such as clips, latches, hooks and loops or similar fasteners.
- the disposable and reusable module connectors 226 and 216 can be adhesive connectors.
- the disposable module housing 222 can include first and second sub-module housing 280 , 290 as shown in FIG. 12 .
- the first and second sub-module housing 280 , 290 can be fabricated from similar materials as the disposable module 220 .
- the first sub-module housing 280 can be configured to support the first lancet station 240 .
- the first sub-module housing 280 can include a first sub-module connector 282 .
- the first sub-module housing 280 supports the first lancet station 240 on a generally planar top surface of the first sub-module housing 280 .
- the first sub-module connector 282 is supported on a generally planar lateral surface of the first sub-module housing 280 . Any of the top, bottom, front, back or lateral surfaces of the first sub-module housing 280 can support the first sub-module connector 282 .
- the second sub-module housing 290 can be configured to support the first strip station 250 .
- the second sub-module housing 290 supports the first strip station 250 on a generally planar top surface.
- the second sub-module housing 290 can include a second sub-module connector 292 that is modularly connectible to the first sub-module connector 282 .
- the second sub-module connector 292 is shown supported on a generally planar lateral surface of the second sub-module housing 290 . Any of the top, bottom, front, back or lateral surfaces of the second sub-module housing 290 can support the second sub-module connector 292 .
- the first and second sub-module connectors 282 and 292 can removably connect by mechanical means such as clips, latches, hook and loop fasteners.
- An adhesive film can be applied on the first and second sub-module connectors 282 and 292 .
- either of the first sub-module 280 or second sub-module 290 can be fabricated together with the reusable module 210 to form a non-separable module.
- the non-separable module can be removably connected with the remaining sub-module by connectors similar to those discussed elsewhere herein. Many variations are contemplated depending on the desired application.
- the biological test kit 200 can have an overall thickness “z” of approximately 12.7 millimeters. In some embodiments, the biological test kit 200 can have a thickness “z” of less than one centimeter and approximately 5 millimeters. In some embodiments, the biological test kit 200 can have a length of less than 10 centimeters and approximately 8 centimeters. In some embodiments, the biological test kit 200 can have a width of approximately 5 centimeters.
- the biological test kit 200 can be fabricated from polymers such as sheets of plastic by machining the sheets to specific dimensions and providing the reusable and disposable module housings 212 , 222 with means to couple to a first lancet station 240 , a first strip station 250 , measurement equipment 214 , display monitor 218 and other components as discussed above.
- the biological test kit 200 can be fabricated by techniques such as molding.
- the disposable module can include a second lancet station 242 and a second strip station 252 .
- the second lancet station 242 and the second strip station 252 can be similar in size and shape to the first lancet station 240 and the first strip station 250 .
- the second lancet station 242 and the second strip station 252 can be supported by the disposable module housing 222 .
- the second lancet station 242 can be configured to remain stationary relative to the disposable module housing 222 .
- the second lancet station 242 can be configured to facilitate generation of a second biological sample.
- the second biological sample can be similar to the first biological sample.
- the second biological sample can be substantially distinguishable from the first biological sample in composition.
- the second strip station 252 can include a second biological strip 262 configured to receive the second biological sample.
- the second biological strip 262 can be of a size and shape to be supported by the second strip station 252 .
- the second biological strip 262 can be fabricated from a sheet of polymeric material with coatings to generate a signal that can be input to the measuring equipment 214 when exposed to the second biological sample.
- the second biological strip 262 can include a coating of an enzyme or a reagent that can electro-chemically react with the second biological sample.
- the second strip station 252 can be configured to provide the second biological sample to the measuring equipment 214 for measurement of the property.
- some biological test kits can have other numbers of lancet stations and/or strip stations.
- some embodiments include four lancet stations (e.g., the biological test kit 200 of FIG. 11 ).
- Some embodiments include different numbers of lancet stations, such as three, five, six, and so on.
- Some embodiments include different numbers of strip stations, such as three, five, six, and so on.
- the number of lancet stations is equal to the number of strip stations. Such embodiments can facilitate one use of a lancet station for each strip station.
- the number of lancet stations and/or strip stations on a disposable module can be tied to the number of times per day a category of patients must measure a biological sample. For example, if a significant percentage of diabetic patients are encouraged to check their blood glucose levels five times per day, a biological test kit can be offered that includes five lancet stations and five strip stations so that the patients can use one disposable module per day.
- the measuring equipment 214 of the biological test kit 200 can include a correlation mechanism configured to identify a measured biological sample as having originated from the first strip station 250 or the second strip station 252 (or other strip stations).
- the measuring equipment 214 can be configured to provide whether the measured biological sample originated from the first strip station 250 or the second strip station 252 to the display monitor 218 for display in a manner known in the art, such as integrated circuit board connections, or similar means.
- the biological test kit 200 includes four lancet stations and four strip stations. It can be appreciated that more than two lancet and strip stations can be included in the biological test kit 200 .
- the measuring equipment 214 can be adapted to include a correlation mechanism that can identify a measured biological sample as having originated from one of the many strip stations.
- the reusable module 210 can include a wireless transmitter supported by the reusable module housing 212 .
- the wireless transmitter can be configured to transmit a signal representative of the measured property to a separate device for display.
- the wireless transmitter can be a Bluetooth transmitter that can interface with a mobile device that is adapted with a Bluetooth receiver, or any similar transmission device.
- the mobile device may be a cell phone or tablet devices that can receive signals transmitted wirelessly, and store the measured property.
- the reusable module 210 can include a mobile device case connector supported by the reusable module housing 212 .
- the mobile device case connector can be configured to detachably connect the reusable module 210 to a mobile device case.
- the mobile device case connector can be supported by any of the top, bottom, front, back or lateral surfaces of the reusable module housing 212 .
- the mobile device case connector can be a clip, latch, hook-and-loop fastener or similar mechanism that can removably connect with a mobile device case.
- the mobile device case connector can be an adhesive coating or film.
- the biological test kit 200 can be coupled to a mobile device case such as a cell phone case or a tablet device case for ease of carrying.
- the disposable module 220 can include an insulin delivery device connector 234 supported by the disposable module housing 222 as shown in FIG. 13 .
- the insulin delivery device connector 234 can be configured to detachably connect the disposable module 220 to an insulin delivery device 230 .
- the insulin delivery device connector 234 can be supported by any of the top, bottom, front, back or lateral surfaces of the disposable module housing.
- the insulin delivery device connector 234 can be a clip, latch, hook-and-loop fastener or similar mechanism that can removably connect with an insulin delivery device 230 .
- the insulin delivery device connector 234 can be an adhesive coating or film.
- the insulin delivery device 230 can be an insulin storage container with a syringe 232 for delivering insulin in users who monitor and manage blood glucose levels.
- the insulin delivery device 230 can be removably connected to the reusable module 210 by the insulin delivery device connector 234 . It should be understood that the disposable module 220 and reusable module 210 need not be removably connected and be fabricated as a single module. In such an embodiment, the insulin delivery device 230 can be removably connected with the single module by the insulin delivery device connector 234 . It should also be understood that the insulin delivery device 230 can be supported by the reusable module 210 in some embodiments.
- FIG. 14 shows a biological test kit 300 according to some embodiments.
- the biological test kit 300 can include a reusable module 310 and a disposable module 320 .
- the disposable module 320 and reusable module 310 can be fabricated as a single module.
- the disposable module 320 and the reusable module 310 can be fabricated as separate modules removably connectable to one another.
- the reusable module 310 can include a reusable module housing 312 , measuring equipment 314 and a reusable module connector 316 (not shown).
- the disposable module 320 can include a disposable module housing 322 , a first lancet station 340 , a first strip station 350 , and a disposable module connector 326 (not shown).
- the disposable module 320 can be removably connected to the reusable module 310 by the disposable module connector 326 and the reusable module connector 316 .
- the first strip station 350 can include a slot 354 in the disposable module housing and a strip container 356 positioned in the slot 354 .
- the slot 354 and the strip container 356 can be fabricated from materials such as plastic.
- the size of the slot and the strip container 356 are such that the strip container 356 can store a first biological strip 360 (or other biological strips) and the strip container 356 can slide in and out of the slot 354 .
- the strip container 356 can be configured to slide into and out of the slot 354 between a closed position and an open position.
- the strip container 356 can be adapted to provide access to the first biological strip 360 when in the open position, as shown in FIG. 13 .
- the strip container 356 can be configured to house a second biological strip 362 (or other biological strips).
- the slot 354 and the strip container 356 can be positioned on the reusable module 310 .
- the reusable and disposable modules may not form a removable connection and are fabricated as a non-separable or integral module.
- the slot 354 and the strip container 356 can be positioned on the non-separable module and configured similar to means discussed above.
- FIGS. 15 - 17 illustrate a biological test kit 400 according to some embodiments.
- the biological test kit 400 can include a reusable module 410 and a disposable module 420 .
- the disposable module 420 and reusable module 410 can be fabricated as a single module.
- the reusable module 410 can include a reusable module housing 412 , measuring equipment 414 and a reusable module connector 416 .
- the disposable module 420 can include a disposable module housing 422 , a first lancet station 440 , a first strip station 452 , and a disposable module connector 426 (not shown).
- the disposable module 420 can be removably connected to the reusable module 410 by the disposable module connector 426 and the reusable module connector 416 .
- the first strip station 452 can include a recess 472 defined in the disposable module housing 422 and a strip station cover 474 .
- the recess 472 shown as a shaded portion in FIG. 14 can be configured to hold a first biological strip 462 .
- the recess 472 can be cut or machined on the disposable module housing 422 to accommodate the first biological strip 462 .
- a second strip station 450 can include a second biological strip 460 positioned in a recess similar to the recess 472 and covered by the strip station cover 474 .
- the strip station cover 474 and the second biological strip 460 are indicated by dashed lines in FIG. 14 . It should be understood that such an embodiment can include any number of strip stations, as discussed elsewhere herein.
- the strip station cover 474 can be removably connected to the disposable module housing 422 .
- the strip station cover can be configured to cover the recess 472 and prevent access to the first biological strip 462 when in a covered position.
- the strip station cover 474 can be configured to permit access to the first biological strip 462 when in an uncovered position.
- the strip station cover 474 can be removably connected to the disposable module housing 422 by mechanical fasteners or adhesives.
- the strip station cover 474 can be a film containing an adhesive to removably connect to the disposable module housing 422 .
- the strip station cover 474 can be peeled to remove the adhesive connection between the strip station cover 474 and the disposable module housing 422 . In the illustrated embodiment shown in FIG.
- strip station cover 474 prevents access to the first biological strip 462 in a covered position.
- a second biological strip 460 can be accessed when a corresponding strip station cover is in an uncovered position.
- FIGS. 16 and 17 show the strip station cover 474 according to some embodiments.
- the strip station cover 474 includes a groove that is configured to engage with the disposable module housing 422 by a friction fit.
- the first and second strip stations 450 and 452 are located on the disposable module 420 .
- the biological test kit 400 can be fabricated as a single component without two modules that can be removably connected (E.g.: the disposable and the reusable module forming a single module). In such an embodiment, the strip station cover 474 forms a friction fit with the single module.
- a biological test kit such as those discussed elsewhere herein can be used for managing blood glucose by periodically testing blood glucose levels.
- the biological test kit can include a lancet device such as those discussed elsewhere herein.
- the lancet device can be used to collect a quantity of a biological sample, such as blood from the user.
- a biological test strip such as glucose strips supported by a strip station can interact with the collected biological sample by electro-chemical or other means.
- the lancet device and the strip station can be supported by a disposable module.
- Measuring equipment supported on a reusable module can measure a biological property, such as blood glucose level in milligrams per deciliter.
- a display monitor supported on the reusable module can display the measured blood glucose level.
- a user can repeat this procedure with a second lancet station and a second strip station included on the disposable module of the biological kit.
- the user can disengage the disposable module by removing the connection between the disposable module connector and the reusable module connector.
- the reusable module can be retained by the user and another disposable module comprising lancet devices and strip stations can be removably connected to the reusable module using techniques discussed elsewhere herein.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Optics & Photonics (AREA)
- Geometry (AREA)
- Manufacturing & Machinery (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
This disclosure provides equipment and processes for blood glucose management. Embodiments may comprise a lancet device that includes a base that supports a lancet and a cover. The cover can move controllably from an un-depressed position to a depressed position when a predetermined force is applied. The cover can provide access to the lancet in the depressed position. In another aspect, a biological test kit may include a reusable module and a disposable module. The disposable module may include one or more lancet devices such as that described above to collect a biological sample, one or more strip stations supporting biological strips and a disposable module connector. The reusable module may support measuring equipment to measure a property of the biological sample and a reusable module connector that engages removably with the disposable module connector.
Description
- This application claims priority to provisional application U.S. Ser. No. 61/817,172 filed Apr. 29, 2013, the disclosure of which is hereby incorporated by reference herein in its entirety.
- This disclosure relates to technology for collecting biological samples to measure a biological property.
- Monitoring blood glucose several times per day is a recommended way for controlling blood glucose levels in patients managing diabetes. Good blood glucose control minimizes loss of life, reduces limb amputations, and enhances quality of life for hundreds of millions of people. It is often recommended by physicians that patients managing diabetes monitor blood glucose levels typically four times a day to mitigate the risks of poor blood glucose control.
- Devices for managing blood glucose typically include a lancing tool. In operation, the tool is opened, and a disposable lancet can be uncovered and inserted into the tool. The user can position the tip against his or her finger and actuate the tool. After that, the blood sample can be transported to a glucose measuring device for analysis. After the lancing event is complete, standard practice is for the user to re-open the tool, and remove and dispose of the lancet. The devices may offer additional features such as a means for the user to enter a depth of insertion of the tool via a dial or a similar input mechanism.
- Blood flow and pain while lancing can be adjusted by the depth of insertion of the lancet. A lancet that is inserted deeper than levels recommended for a specific user can cause a high volume of blood flow and significant pain. By contrast, a lancet that is inserted less deep than recommended levels introduces less pain, but does not draw sufficient quantity of blood for testing blood glucose levels. The lancet can also be replaced with each use to prevent risk of infection. Replacing a lancet with each use can also prevent the lancet from becoming duller with use, and consequently provide less pain while lancing. Pain, expense, and user-unfriendliness are common reasons why diabetes patients may be less likely to monitor their blood glucose levels with diligence.
- In one aspect, this disclosure teaches an easy-to-use lancet device that produces a sufficient amount of blood without causing undue pain so that patients are more likely to monitor biological properties for disease management. A lancet device can include a base that includes a support surface, a lancet and a cover. The cover can include a peripheral edge along which the cover is connected to the base, a cover region, a lancet aperture, and a peripheral hinge near the peripheral edge. The cover region can cover the lancet when the cover is in an un-depressed position. The lancet can be configured to protrude through the lancet aperture when the cover is in a depressed position. The peripheral hinge can facilitate controlled movement of the cover from the un-depressed position to the depressed position upon application of a predetermined depression force.
- A method of collecting a biological sample may include providing a lancet device such as that discussed above. A predetermined force can be applied on the cover region. The cover can move from an un-depressed position in which the cover region covers the lancet to a depressed position in which the lancet protrudes through the lancet aperture and exposes biological fluid. A quantity of the biological fluid as the biological sample can be collected.
- Certain lancet devices in accordance with embodiments of the present invention may have one or more advantages. For example, the lancet device can be easy to use because it eliminates assembly of multiple pieces. The lancet device can controllably move the skin surface onto and off of a lancet to minimize pain and maximize blood flow. In some instances, different lancet devices can be offered for users with different anatomical features—e.g., one lancet device for users with relatively thick finger skin, and another lancet device for users with relatively thin finger skin. Some embodiments with multiple lancet stations provide visual evidence of which lancet stations have been used and which ones have not yet been used. Some embodiments prevent a lancet station from being used more than once. Some embodiments provide feedback (e.g., audible and/or tactile) as lancing occurs to increase patient comfort. The lancet device can provide increased compliance because of its small size, portability and less pain during use, fewer complications during collection of the biological sample and decreased total cost.
- In another aspect, this disclosure teaches a compact biological test kit for measuring a property of a biological sample that enables re-use of reusable components and disposal of disposable components. The biological test kit can include a reusable module and a disposable module. The disposable module can include one or more lancet devices, such as those described elsewhere herein, and one or more strip stations. The strip station can support one or more biological test strips that can interact with the collected biological sample. The reusable module can support measuring equipment that can measure a property of the biological sample. A reusable module connector and a disposable module connector may removably connect the reusable module and the disposable module. A display monitor can be included with the reusable module to display the measured property.
- Certain biological test kits in accordance with embodiments of the present invention may have one or more advantages. For example, the biological test kit can offer ease of use and portability. In some embodiments, different components can be replaced at different intervals. For example, in embodiments with a reusable module and a disposable module, the disposable module may be replaced with each use (or after a relatively small number of uses), while the reusable module may be replaced at significantly longer intervals. In embodiments in which the disposable module is made up of a lancet station module and a strip station module, the lancet station module and the strip station module can be replaced at different intervals. Multiple lancing events can be performed with the same device, enabling a user to monitor blood glucose levels at a recommended interval. The biological test kit can enable one finger operation. In some embodiments, the entire biological test kit can be roughly the size of a credit card, which can make it more accessible, portable, increase testing compliance and enable a connected real-time management of glucose.
- The details of one or more examples are set forth in the accompanying drawings and the description below. Other features, objects, and advantages will be apparent from the description and drawings, and from the claims.
-
FIG. 1 is a front elevation view of a lancet device according to embodiments of the invention with the cover in an un-depressed position. -
FIG. 2 is a front elevation view of the lancet device ofFIG. 1 with the cover in a depressed position. -
FIG. 3 is a front elevation view of a lancet device according to embodiments of the invention with the cover in the depressed position. -
FIG. 4(a) is a front elevation view of a lancet device according to embodiments of the invention with the cover in the un-depressed position. -
FIG. 4(b) is a top plan view of a lancet device ofFIG. 4(a) . -
FIG. 5(a) is a front elevation view of a lancet device according to embodiments of the invention with the cover in the un-depressed position. -
FIG. 5(b) is a top plan view of the lancet device ofFIG. 5(a) . -
FIG. 6 is a graph that shows the force applied to the lancet cover at various stages of use of a lancet device. -
FIG. 7 is a front elevation view of a lancet device according to embodiments of the invention with the cover in the un-depressed position. -
FIG. 8 is a top plan view of a lancet device according to embodiments of the invention. -
FIG. 9(a) is a front elevation view of a lancet device according to embodiments of the invention with the cover in the un-depressed position, and a cap in a capped position. -
FIG. 9(b) is a top plan view of the lancet device ofFIG. 9(a) with the cap in the capped position. -
FIG. 10(a) is a top plan view of a biological test kit according to embodiments of the invention. -
FIG. 10(b) is a front elevation view of the biological test kit ofFIG. 10(a) . -
FIG. 11 is an exploded front elevation view of a biological test kit according to embodiments of the invention. -
FIG. 12 is an exploded perspective view of a biological test kit according to embodiments of the invention. -
FIG. 13 is a perspective view of a biological test kit according to embodiments of the invention. -
FIG. 14 is a top plan view of a biological test kit according to embodiments of the invention. -
FIG. 15 is a top plan view of a biological test kit according to embodiments of the invention. -
FIG. 16 is a perspective view of a biological test kit according to embodiments of the invention. -
FIG. 17 is a perspective view of a biological test kit according to embodiments of the invention. - The following detailed description is exemplary in nature and is not intended to limit the scope, applicability, or configuration of the invention in any way. Rather, the following description provides some practical illustrations for implementing examples of the present invention. Examples of constructions, materials, dimensions, and manufacturing processes are provided for selected elements, and all other elements employ that which is known to those of ordinary skill in the field of the invention. Those skilled in the art will recognize that many of the noted examples have a variety of suitable alternatives.
- Embodiments of the invention include a
lancet device 100 to collect biological samples. Thelancet device 100 can include abase 102, alancet 104, and acover 106. The base 102 can include asupport surface 108. The base 102 can be made of a material that is rigid in comparison to thecover 106. The base 102 can be made of materials such as a rigid polymer, metal, etc. The base 102 can be of any desired size or shape. The base 102 may be operably coupled to thecover 106. Thesupport surface 108 may be a generally planar surface that can house thelancet 104. Thesupport surface 108 in the illustrated embodiment is an upper surface of thebase 102. Thesupport surface 108 can be made of similar materials as thebase 102 and can be rigid in comparison to thecover 106. - The base 102 can support a
lancet 104, which can extend away from thesupport surface 108 at an angle of approximately 90°. In many embodiments, thelancet 104 can remain stationary with respect to thebase 102. Thelancet 104 can include a lancingedge 150 adapted to make an incision or a puncture on a surface (e.g., skin). Thelancet 104 can be made of materials such as stainless steel or similar alloys. The lancingedge 150 can be fabricated by grinding or a similar machining technique so that the lancing edge is of a specific geometry and sharpness to pierce a surface such as skin without causing thelancet 104 to break. Thelancet 104 can be configured to pierce the skin of a user to collect a quantity of blood sample. - The
cover 106 can be operably coupled to thebase 102 of thelancet device 100. Thecover 106 can include aperipheral edge 110 along which the cover is connected to the base. In some embodiments, thecover 106 can be coupled to the base 102 at a selected location near theperipheral edge 110. In some embodiments, thecover 106 can be coupled to thebase 102 along the entireperipheral edge 110. Thecover 106 can be made of a polymeric material that has a sufficiently large elasticity to move a specific distance when a specified force is applied on the cover. The polymeric or metallic material may be selected to include favorable elastic properties that allow the cover to move in a controlled manner. Instead of or in addition to engineered polymers, a spring, foam, cam and helix device, or other suitable mechanism can be included between thecover 106 and the base 102 that facilitates controlled movement of the cover when a predetermined depression force is applied. - The
cover 106 can include acover region 120 configured to cover thelancet 104 when thecover 106 is in an un-depressed position. Thecover region 120 has a hemispherical or domed shape in the un-depressed position in the illustrated embodiment. The height of the cover region above the base is indicated as “h”, and the diameter of the cover region in the un-depressed position is indicated as “d”. It can be appreciated that thecover region 120 can have any desired shape in the un-depressed position such as a cuboidal cover region with rounded edges or similar shapes. In some embodiments, thecover 106 can include a diving board configuration. In some embodiments, thecover region 120 can comprise a cover region geometry that includes cover region edges 122 and 124. The cover region edges 122 and 124 define a cover region wall thickness “a”. Thecover region 120 can move a specific distance when a predetermined depression force is applied on thecover region 120. The predetermined depression force can cause thecover region 120 to move in a controlled manner from the un-depressed position, to a depressed position, shown inFIGS. 2 and 3 . When the cover region is in the depressed position, thecover region 120 provides access to thelancet 104. - In some embodiments, the
cover 106 can include aperipheral hinge 116 near theperipheral edge 110 as shown inFIG. 4(a) . In some embodiments, theperipheral hinge 116 can include peripheral hinge geometry. The peripheral hinge geometry can comprise a variety of configurations. For example, in some embodiments, peripheral hinge edges 112, 114 can define a peripheral hinge wall thickness “b” as shown inFIG. 4(a) . In some embodiments, the peripheral hinge geometry can includeperipheral hinge edge 112 orperipheral hinge edge 114 but not both. In some embodiments, the peripheral hinge geometry can include rounded or angular hinges. Peripheral hinge edges 112, 114 can include or can be replaced by curved, angled or box-shaped notches or projections near theperipheral edge 110. For instance, the notches can be angled as V or H-shaped notches with a projection of complementary shape. The notches or projections can act as a hinge joint and can resemble a knee or an elbow joint. It can be appreciated that other hinge shapes that introduce a similar effect can be included without any loss of functionality. Theperipheral hinge 116 facilitates the controlled movement of thecover 106 from the un-depressed position to the depressed position upon application of a predetermined depression force. - In many embodiments, the peripheral hinge geometry can differ from the cover region geometry. For example, the cover region thickness “a” can be different from the peripheral hinge thickness “b”. In some embodiments, the peripheral hinge wall thickness “b” is between approximately 25% and approximately 50% of the cover region wall thickness “a”. In some embodiments, the peripheral hinge wall thickness “b” is less than half of the cover region wall thickness “a”. In some embodiments, the peripheral hinge wall thickness “b” is between ⅔ and ¾ the cover region wall thickness “a”. In some embodiments, the peripheral hinge wall thickness “b” is less than ⅔ the cover region wall thickness “a”. In some embodiments, the peripheral hinge wall thickness “b” is less than ¾ the cover region wall thickness “a”. The cover region thickness “a” and the peripheral wall hinge thickness “b” can be varied during fabrication of the device.
- The
lancet device 100 can be configured such that thecover 106 moves from the un-depressed position to the depressed position upon application of a predetermined force that a typical user would be capable of applying. In some embodiments, the predetermined depression force can be between approximately 500 and approximately 1500 grams. In some embodiments the predetermined depression force can be between approximately 700 grams and approximately 2000 grams. In some embodiments, the predetermined depression force can be between approximately 800 grams and approximately 1200 grams. In some embodiments, the predetermined depression force can be between approximately 700 grams and approximately 800 grams. In some embodiments, the predetermined depression force can be between approximately 800 grams and approximately 900 grams. In some embodiments, the predetermined depression force can be between approximately 900 grams and approximately 1000 grams. In some embodiments, the predetermined depression force can be between approximately 1000 grams and approximately 1100 grams. In some embodiments, the predetermined depression force can be between approximately 1100 grams and approximately 1200 grams. In some embodiments, the predetermined depression force can be between approximately 1200 grams and approximately 1300 grams. In some embodiments, the predetermined depression force can be between approximately 1300 grams and approximately 1400 grams. In some embodiments, the predetermined depression force can be between approximately 1400 grams and approximately 1500 grams. In some embodiments, the predetermined depression force can be between approximately 1500 grams and approximately 1600 grams. In some embodiments, the predetermined depression force can be between approximately 1600 grams and approximately 1700 grams. In some embodiments, the predetermined depression force can be between approximately 1700 grams and approximately 1800 grams. In some embodiments, the predetermined depression force can be between approximately 1800 grams and approximately 1900 grams. In some embodiments, the predetermined depression force can be between approximately 1900 grams and approximately 2000 grams. In some embodiments, the predetermined depression force can be greater than 2000 grams. The distance traveled by thecover region 120 between the un-depressed (shown as dashed lines inFIGS. 2-3 ) and the depressed position, is indicated by a depression depth “f” inFIGS. 2-3 . The depression depth “f” can be between approximately 0.2 millimeters and approximately 4 millimeters when the predetermined force is applied. Different configurations with different required depression forces may be offered for different kinds of users. The depression depth can be adjusted by including a design of thecover region 120 with a diameter “e” and a height “g” that are different from the illustrated diameter “d” and the illustrated height “h”. - In some embodiments, the
cover 106 can include alancet aperture 132 through which thelancet 104 is configured to protrude when thecover 106 is in a depressed position. Thelancet aperture 132 is illustrated as a circular opening inFIG. 5(b) , but can also be of other shapes. The diameter or the opening size of thelancet aperture 132 is at least equal to the thickness of the lancet as shown inFIG. 5(a) so that thelancet 104 protrudes out of thelancet aperture 132 when thecover 106 is in the depressed position. Thelancet aperture 132 may be introduced in thecover region 120 by cutting or tearing thecover region 120 appropriately to the required geometry and dimensions of thelancet aperture 132. Thelancet 104 can protrude through thelancet aperture 132 to a protrusion height “c” when thecover 106 is in the depressed position as shown inFIGS. 2-3 . In some embodiments, the protrusion height “c” of thelancet 104 can be between approximately 0.3 millimeters and approximately 1.2 millimeters. The protrusion height “c” can be selected so that optimal quantity of biological sample is collected. For example, if the lancet device is used for collecting blood from a user by lancing the user's finger skin, an appropriate protrusion height “c” can ensure optimal quantity of blood is drawn from the user's finger and at the same time minimizing pain in the user due to lancing. Anatomical features such as thickness of the finger skin, pain tolerance, and blood flow through a user's blood vessels can be considered by a user in deciding on a suitable protrusion height of the lancet. A user can, for instance, apply less force on thecover region 120 of thelancet device 100, causing the protrusion height “c” to be lower, than in the case if the user where to apply more force on thecover region 120. - In some embodiments, the
cover 106 can be configured to provide an auditory and/or tactile response as thecover 106 moves from the un-depressed position to the depressed position upon application of the predetermined depression force. When thelancet device 100 is used to collect a biological sample such as a blood sample from a user by lancing the user's skin, the auditory and/or tactile response can facilitate lower pain perception by a user. In some embodiments, thecover 106 is engineered from a material such that the material provides an auditory response when it moves from the un-depressed position to the depressed position. In some such embodiments, the auditory response can be a pleasing sound (e.g., a snapping sound) when the force due to the user's finger pressure on thecover 106 equals the predetermined depression force. The pleasing sound can cause the user to perceive lower pain due to lancing. In some such embodiments, the pleasing sound can be accompanied by a tactile response (e.g., a sensation that thecover 106 has snapped past a threshold point), which can cause lower pain perception. In some embodiments, the tactile response can be provided with little or no auditory response. In some embodiments, thelancet 104 does not vibrate during lancing leading to lower pain perception. - In some embodiments, the
cover 106 can be configured to provide a force response. This force response is illustrated inFIG. 6 . The force response facilitates movement of thecover 106 from the depressed position back to the un-depressed position upon removal of the predetermined depression force. In some embodiments, thecover 106 is made of materials that can be engineered to provide the force response. The force response can be used to facilitate lower pain perception by a user. As shown inFIG. 6 , thecover 106 can be configured such that when the force due to finger pressure equals the predetermined depression force (FIG. 6 , Point 2), the design features of thecover 106 can move from resisting the depression force to acceleration in downward movement until it reaches a designed stop (FIG. 6 , Point 3). After the skin has been lanced due to this movement, the depression force can lift from the cover (FIG. 6 , Point 4). The design features of thecover region 120 can create a spring-like response accelerating thecover 106 back up which pushes upward and lifting the skin off the lancet 104 (FIG. 6 , Point 5). Finally the skin is lifted from thecover 106 so that no force is applied (FIG. 6 , Point 6). - In some embodiments, the
cover 106 can include arelease aperture 134 to release trapped air that might impede controlled movement of thecover 106. Therelease aperture 134 can be located near theperipheral edge 110 of thecover 106. Therelease aperture 134 is illustrated as a circular opening inFIG. 5(b) . It can be appreciated that therelease aperture 134 can be of other geometrical shapes without loss of functionality. Therelease aperture 134 can be of a size on the order of the size of thelancet aperture 132. Any trapped air near theperipheral edge 110 of thecover 106 can resist movement of thecover region 120 toward the depressed position when the predetermined force is applied. Therelease aperture 134 allows the trapped air near the peripheral edge 110 (the air cannot escape through thelancet aperture 132 because thelancet aperture 132 is essentially sealed by the user's skin) to escape through therelease aperture 134 outwardly from theperipheral edge 110, thereby facilitating controlled movement of thecover region 120 between the un-depressed and depressed positions. - In some embodiments, the
cover 106 can include aspike 162 extending toward thebase 102. The spike can be of a material similar to thelancet 104, or other suitable material. In this embodiment, thelancet device 100 can include acavity 164 on thebase 102 under thecover 106. Thecavity 164 may include acavity wall 166 that holds pressurized gas. As thecover 106 moves from the un-depressed position to the depressed position, thespike 162 can moves toward thecavity 164, eventually piercing thecavity wall 166. Thecavity 164 can release pressurized gas upon being pierced by thespike 162. The released gas can exert pressure on thecover 106 to push thecover 106 from the depressed position back to the un-depressed position. The pressurized gas combination can be used in addition to thecover 106 with engineered materials capable of providing a force response. - In some embodiments, the base 102 can include a
visual indicator 170 that shows if the cover has been moved from the un-depressed position to the depressed position as shown inFIG. 8 . The base 102 can be made of a material that can be configured to provide a pattern or a color change. The color or pattern change can occur when the applied force on thecover region 120, such as due to finger pressure when lancing, exceeds the predetermined depression force. Thevisual indicator 170 can include a color or pattern changing surface made of materials such as pressure sensitive coating or films operably coupled to thebase 102. Thevisual indicator 170 facilitates a user in identifying whether a lancet device was previously used and allow for single use of a lancet device. Visual indicators other than those shown may be incorporated into lancet devices in various embodiments of the present invention. - In some embodiments, the base 102 can include a
stop 180 under thecover 106. Thestop 180 can be configured to dictate a distance by which thelancet 104 is configured to protrude through the lancet aperture when thecover 106 is in the depressed position. The size of thestop 180 can be determined during manufacture based on the depth of insertion of thelancet 104. Thestop 180 is illustrated as a rectangular projection inFIG. 3 . It can be appreciated that thestop 180 can have any desired shape, such as a hemispherical projection or other shapes. Thestop 180 can be fabricated from materials similar to thebase 102. Thestop 180 can be included with the base 102 as a single component during fabrication. - In some embodiments, the lancet device can include a
cap 140 as shown inFIGS. 9(a)-9(b) . Thecap 140 can operably couple with the base 102 by ahinge connection 142 as shown in the illustrated embodiment, or by similar mechanical fasteners. Thecap 140 can be made of materials similar to that of thebase 102. Thecap 140 can be positioned from a capped position to an uncapped position. In the capped position, thecap 140 is in close proximity to thebase 102, and encloses thecover 106, thereby preventing access to thelancet 104. In the uncapped position, thecap 140 facilitates access to thelancet 104. Thecap 140 can be configured to act as a sterile barrier when in the capped position to isolate thelancet 104 from contaminants. - In use, a
lancet device 100 such as those discussed elsewhere herein can be used for collecting blood from a user for monitoring glucose. In some embodiments, thelancet device 100 can be used for collecting similar biological samples. A user can apply a force on thecover region 120. The force applied by the user can be due to finger pressure. The force applied on thecover region 120 may increase as indicated by the force ramp during stages 1-2 inFIG. 6 . If the force applied by the user is equal to or greater than a predetermined force, thecover 106 can move from an un-depressed position in which the cover region covers the lancet to a depressed position during stage 2-3 inFIG. 6 . Thelancet 104 protrudes through thelancet aperture 132 in the depressed position and exposes biological fluid. A quantity of the biological fluid as the biological sample can be collected during stages 3-4 inFIG. 6 . - When the user stops applying force on the
cover region 120, thecover region 120 exerts a pushing force opposite to the force applied by the user. The pushing force can be as a result of tension in thecover region 120 due to its material elasticity and/or by one or more mechanical tensioning elements included in the cover region as discussed elsewhere herein. The pushing force from thecover region 120 gradually increases as shown by the force ramp during stages 4-5 inFIG. 6 . Whenstage 5 is reached, thecover region 120 has moved from the depressed position back to the un-depressed position. The user can then remove the finger from the lancet device and proceed to provide the biological sample for the desired purpose. - Some embodiments of the present invention involve a
biological test kit 200. Thebiological test kit 200 can include areusable module 210 and adisposable module 220. In some embodiments, thedisposable module 220 andreusable module 210 can be fabricated as a single, integral module and cannot be modularly connected to and disconnected from one another. In many embodiments, thedisposable module 220 can be removably connected with thereusable module 210. Thebiological test kit 200 is illustrated as having a rectangular shape inFIG. 7 , but can have any desired shape such as square or oval without loss of functionality. In the illustrated embodiment, the biological test kit has a length “x”, a width “y” and a thickness “z”. The thickness “z” of thebiological test kit 200 can be substantially less than the length “x” or the width “y”. Thebiological test kit 200 can be fabricated by molding a rigid polymer material such as plastic or by machining a similar material. In some embodiments, the thickness “z” can be less than or equal to ½ inch. In some embodiments, the thickness “z” can be less than or equal to 0.35 inches. In some embodiments, the thickness “z” can be less than or equal to 0.2 inches. - In some embodiments, the
reusable module 210 can include areusable module housing 212, measuringequipment 214, and areusable module connector 216. Thereusable module housing 212 can include a generally planar support surface to support the measuringequipment 214. In some embodiments, thereusable module housing 212 may include a second support surface. The second support surface can house thereusable module connector 216. The planar support surface and the second support surface can be any of the surfaces of thereusable module 210. In the illustrated embodiment, the planar support surface supporting themeasuring equipment 214 is the top surface of thereusable module housing 212. The support surface that houses thereusable module connector 216 is a lateral surface of thereusable module housing 212. Any of the top, bottom, front, back or lateral surfaces can house the measuringequipment 214 andreusable module connector 216 without loss of functionality of thebiological test kit 200. - The measuring
equipment 214 and thereusable module 210 connector can be supported by thereusable module housing 212. The measuringequipment 214 can be configured to measure a property of a biological sample. The measuringequipment 214 can include a sensor that can measure a specific property of the biological sample by electro-chemical means or other methods known in the arts. The measuringequipment 214 can, for instance, be configured to measure blood glucose level. For example, a chemical reaction can occur between a specific quantity of blood glucose, and an enzyme or a reagent that generates an electric current at an electrode. The measuringequipment 214 can then be configured to sense the electric current and calibrated to correlate a specific value of an electric current to a blood glucose level. - In some embodiments, the
reusable module 210 can include adisplay monitor 218 supported by thereusable module housing 212 and configured to display the measured property. The display monitor 218 can be a LCD panel or LED or similar display device that can display the measured property and/or other relevant information. The display monitor 218 can be supported by thereusable module housing 212 by any of the known methods, including microfabrication techniques. In the illustrated embodiment, thedisplay monitor 218 is a rectangular panel of diagonal length “w.” It may be appreciated that the display monitor 218 can be of any desired size or shape to display the measured property (e.g., as alphanumeric characters). Thedisplay monitor 218, for instance, can display blood glucose level as a numerical value in milligrams per deciliter, when thebiological test kit 200 collects blood from users for diabetes management. - The
disposable module 220 can include adisposable module housing 222, at least one lancet station, at least one strip station, and adisposable module connector 226. Thedisposable module housing 222 can be made of a rigid polymer material such as plastic. Thedisposable module housing 222 may include a support surface to house at least one lancet station and one strip station, and can be adapted to provide support to multiple lancet and strip stations or other components. In some embodiments, thedisposable module housing 222 can include a second support surface that house thedisposable module connector 226. - The
first lancet station 240 can be supported by and is stationary relative to thedisposable module housing 222. Thefirst lancet station 240 is illustrated in the embodiment as comprising a circular station, though other configurations are contemplated as within the scope of this disclosure. Thefirst lancet station 240 can include a device such as thelancet device 100 described elsewhere herein. Thefirst lancet station 240 can comprise a cover supported by thedisposable module housing 222. The cover can be fabricated from a polymeric material with sufficient elasticity to depress to a specific height upon application of a predetermined force. The cover can include an aperture that provides access to a lancet. The lancet can be supported by the disposable module housing. Thefirst lancet station 240 can include any of the embodiments of thelancet device 100. Thefirst lancet station 240 can facilitate the generation of a first biological sample. The first biological sample, for instance, can be a small quantity of blood for monitoring blood glucose. - The
first strip station 250 can be supported by thedisposable module housing 222. Thefirst strip station 250 can include a firstbiological strip 260 configured to receive the first biological sample. The firstbiological strip 260 can be rectangular with a thickness much smaller than length and width. The firstbiological strip 260 can be fabricated from a sheet of polymeric material with coatings to generate a signal that can be input to themeasuring equipment 214 when exposed to the first biological sample. The firstbiological strip 260 can include a coating of an enzyme or a reagent that can electro-chemically react with the first biological sample. Thefirst strip station 250 can be configured to provide the first biological sample to themeasuring equipment 214 for measurement of the property. - The
disposable module connector 226 can be supported by thedisposable module housing 222 and can be modularly connectible to thereusable module connector 216. In some embodiments, thedisposable module connector 226 and thereusable module connector 216 can together comprise an interlocking fastener. The disposable andreusable module connectors reusable module connectors - In some embodiments, the
disposable module housing 222 can include first and secondsub-module housing FIG. 12 . The first and secondsub-module housing disposable module 220. The firstsub-module housing 280 can be configured to support thefirst lancet station 240. The firstsub-module housing 280 can include a firstsub-module connector 282. In the illustrated embodiment, the firstsub-module housing 280 supports thefirst lancet station 240 on a generally planar top surface of the firstsub-module housing 280. The firstsub-module connector 282 is supported on a generally planar lateral surface of the firstsub-module housing 280. Any of the top, bottom, front, back or lateral surfaces of the firstsub-module housing 280 can support the firstsub-module connector 282. - The second
sub-module housing 290 can be configured to support thefirst strip station 250. The secondsub-module housing 290 supports thefirst strip station 250 on a generally planar top surface. The secondsub-module housing 290 can include a secondsub-module connector 292 that is modularly connectible to the firstsub-module connector 282. The secondsub-module connector 292 is shown supported on a generally planar lateral surface of the secondsub-module housing 290. Any of the top, bottom, front, back or lateral surfaces of the secondsub-module housing 290 can support the secondsub-module connector 292. The first and secondsub-module connectors sub-module connectors reusable module 210 to form a non-separable module. In such an embodiment, the non-separable module can be removably connected with the remaining sub-module by connectors similar to those discussed elsewhere herein. Many variations are contemplated depending on the desired application. - In some embodiments, the
biological test kit 200 can have an overall thickness “z” of approximately 12.7 millimeters. In some embodiments, thebiological test kit 200 can have a thickness “z” of less than one centimeter and approximately 5 millimeters. In some embodiments, thebiological test kit 200 can have a length of less than 10 centimeters and approximately 8 centimeters. In some embodiments, thebiological test kit 200 can have a width of approximately 5 centimeters. Thebiological test kit 200 can be fabricated from polymers such as sheets of plastic by machining the sheets to specific dimensions and providing the reusable anddisposable module housings first lancet station 240, afirst strip station 250,measurement equipment 214, display monitor 218 and other components as discussed above. Thebiological test kit 200 can be fabricated by techniques such as molding. - In some embodiments, the disposable module can include a
second lancet station 242 and asecond strip station 252. Thesecond lancet station 242 and thesecond strip station 252 can be similar in size and shape to thefirst lancet station 240 and thefirst strip station 250. Thesecond lancet station 242 and thesecond strip station 252 can be supported by thedisposable module housing 222. Thesecond lancet station 242 can be configured to remain stationary relative to thedisposable module housing 222. Thesecond lancet station 242 can be configured to facilitate generation of a second biological sample. The second biological sample can be similar to the first biological sample. The second biological sample can be substantially distinguishable from the first biological sample in composition. - The
second strip station 252 can include a secondbiological strip 262 configured to receive the second biological sample. The secondbiological strip 262 can be of a size and shape to be supported by thesecond strip station 252. The secondbiological strip 262 can be fabricated from a sheet of polymeric material with coatings to generate a signal that can be input to themeasuring equipment 214 when exposed to the second biological sample. The secondbiological strip 262 can include a coating of an enzyme or a reagent that can electro-chemically react with the second biological sample. Thesecond strip station 252 can be configured to provide the second biological sample to themeasuring equipment 214 for measurement of the property. - It should be understood that, while embodiments discussed elsewhere herein include one or two lancet stations and one or two strip stations, some biological test kits can have other numbers of lancet stations and/or strip stations. For example, some embodiments include four lancet stations (e.g., the
biological test kit 200 ofFIG. 11 ). Some embodiments include different numbers of lancet stations, such as three, five, six, and so on. Some embodiments include different numbers of strip stations, such as three, five, six, and so on. In many embodiments, the number of lancet stations is equal to the number of strip stations. Such embodiments can facilitate one use of a lancet station for each strip station. In some embodiments, the number of lancet stations and/or strip stations on a disposable module can be tied to the number of times per day a category of patients must measure a biological sample. For example, if a significant percentage of diabetic patients are encouraged to check their blood glucose levels five times per day, a biological test kit can be offered that includes five lancet stations and five strip stations so that the patients can use one disposable module per day. - In some embodiments, the measuring
equipment 214 of thebiological test kit 200 can include a correlation mechanism configured to identify a measured biological sample as having originated from thefirst strip station 250 or the second strip station 252 (or other strip stations). The measuringequipment 214 can be configured to provide whether the measured biological sample originated from thefirst strip station 250 or thesecond strip station 252 to the display monitor 218 for display in a manner known in the art, such as integrated circuit board connections, or similar means. In the embodiment shown inFIGS. 7-10 , thebiological test kit 200 includes four lancet stations and four strip stations. It can be appreciated that more than two lancet and strip stations can be included in thebiological test kit 200. The measuringequipment 214 can be adapted to include a correlation mechanism that can identify a measured biological sample as having originated from one of the many strip stations. - In some embodiments, the
reusable module 210 can include a wireless transmitter supported by thereusable module housing 212. The wireless transmitter can be configured to transmit a signal representative of the measured property to a separate device for display. The wireless transmitter can be a Bluetooth transmitter that can interface with a mobile device that is adapted with a Bluetooth receiver, or any similar transmission device. The mobile device may be a cell phone or tablet devices that can receive signals transmitted wirelessly, and store the measured property. - In some embodiments, the
reusable module 210 can include a mobile device case connector supported by thereusable module housing 212. The mobile device case connector can be configured to detachably connect thereusable module 210 to a mobile device case. The mobile device case connector can be supported by any of the top, bottom, front, back or lateral surfaces of thereusable module housing 212. The mobile device case connector can be a clip, latch, hook-and-loop fastener or similar mechanism that can removably connect with a mobile device case. The mobile device case connector can be an adhesive coating or film. Thebiological test kit 200 can be coupled to a mobile device case such as a cell phone case or a tablet device case for ease of carrying. - In some embodiments, the
disposable module 220 can include an insulindelivery device connector 234 supported by thedisposable module housing 222 as shown inFIG. 13 . The insulindelivery device connector 234 can be configured to detachably connect thedisposable module 220 to aninsulin delivery device 230. The insulindelivery device connector 234 can be supported by any of the top, bottom, front, back or lateral surfaces of the disposable module housing. The insulindelivery device connector 234 can be a clip, latch, hook-and-loop fastener or similar mechanism that can removably connect with aninsulin delivery device 230. The insulindelivery device connector 234 can be an adhesive coating or film. Theinsulin delivery device 230 can be an insulin storage container with asyringe 232 for delivering insulin in users who monitor and manage blood glucose levels. Theinsulin delivery device 230 can be removably connected to thereusable module 210 by the insulindelivery device connector 234. It should be understood that thedisposable module 220 andreusable module 210 need not be removably connected and be fabricated as a single module. In such an embodiment, theinsulin delivery device 230 can be removably connected with the single module by the insulindelivery device connector 234. It should also be understood that theinsulin delivery device 230 can be supported by thereusable module 210 in some embodiments. -
FIG. 14 shows abiological test kit 300 according to some embodiments. Thebiological test kit 300 can include areusable module 310 and adisposable module 320. In some embodiments, thedisposable module 320 andreusable module 310 can be fabricated as a single module. In many embodiments, thedisposable module 320 and thereusable module 310 can be fabricated as separate modules removably connectable to one another. Thereusable module 310 can include areusable module housing 312, measuringequipment 314 and a reusable module connector 316 (not shown). Thedisposable module 320 can include adisposable module housing 322, afirst lancet station 340, afirst strip station 350, and a disposable module connector 326 (not shown). Thedisposable module 320 can be removably connected to thereusable module 310 by the disposable module connector 326 and the reusable module connector 316. Thefirst strip station 350 can include aslot 354 in the disposable module housing and astrip container 356 positioned in theslot 354. Theslot 354 and thestrip container 356 can be fabricated from materials such as plastic. The size of the slot and thestrip container 356 are such that thestrip container 356 can store a first biological strip 360 (or other biological strips) and thestrip container 356 can slide in and out of theslot 354. Thestrip container 356 can be configured to slide into and out of theslot 354 between a closed position and an open position. Thestrip container 356 can be adapted to provide access to the firstbiological strip 360 when in the open position, as shown inFIG. 13 . Thestrip container 356 can be configured to house a second biological strip 362 (or other biological strips). It can be appreciated theslot 354 and thestrip container 356 can be positioned on thereusable module 310. In some embodiments of thebiological test kit 300, the reusable and disposable modules may not form a removable connection and are fabricated as a non-separable or integral module. In such an embodiment, theslot 354 and thestrip container 356 can be positioned on the non-separable module and configured similar to means discussed above. -
FIGS. 15-17 illustrate abiological test kit 400 according to some embodiments. Thebiological test kit 400 can include areusable module 410 and adisposable module 420. Thedisposable module 420 andreusable module 410 can be fabricated as a single module. Thereusable module 410 can include areusable module housing 412, measuringequipment 414 and a reusable module connector 416. Thedisposable module 420 can include adisposable module housing 422, afirst lancet station 440, afirst strip station 452, and a disposable module connector 426 (not shown). Thedisposable module 420 can be removably connected to thereusable module 410 by the disposable module connector 426 and the reusable module connector 416. Thefirst strip station 452 can include arecess 472 defined in thedisposable module housing 422 and astrip station cover 474. Therecess 472 shown as a shaded portion inFIG. 14 can be configured to hold a firstbiological strip 462. Therecess 472 can be cut or machined on thedisposable module housing 422 to accommodate the firstbiological strip 462. Asecond strip station 450 can include a secondbiological strip 460 positioned in a recess similar to therecess 472 and covered by thestrip station cover 474. Thestrip station cover 474 and the secondbiological strip 460 are indicated by dashed lines inFIG. 14 . It should be understood that such an embodiment can include any number of strip stations, as discussed elsewhere herein. - The
strip station cover 474 can be removably connected to thedisposable module housing 422. The strip station cover can be configured to cover therecess 472 and prevent access to the firstbiological strip 462 when in a covered position. Thestrip station cover 474 can be configured to permit access to the firstbiological strip 462 when in an uncovered position. Thestrip station cover 474 can be removably connected to thedisposable module housing 422 by mechanical fasteners or adhesives. Thestrip station cover 474 can be a film containing an adhesive to removably connect to thedisposable module housing 422. Thestrip station cover 474 can be peeled to remove the adhesive connection between thestrip station cover 474 and thedisposable module housing 422. In the illustrated embodiment shown inFIG. 15 ,strip station cover 474 prevents access to the firstbiological strip 462 in a covered position. A secondbiological strip 460 can be accessed when a corresponding strip station cover is in an uncovered position.FIGS. 16 and 17 show thestrip station cover 474 according to some embodiments. In the illustrated embodiments, thestrip station cover 474 includes a groove that is configured to engage with thedisposable module housing 422 by a friction fit. In the illustrated embodiments inFIGS. 15-17 , the first andsecond strip stations disposable module 420. It can be appreciated that thebiological test kit 400 can be fabricated as a single component without two modules that can be removably connected (E.g.: the disposable and the reusable module forming a single module). In such an embodiment, thestrip station cover 474 forms a friction fit with the single module. - In use, a biological test kit such as those discussed elsewhere herein can be used for managing blood glucose by periodically testing blood glucose levels. The biological test kit can include a lancet device such as those discussed elsewhere herein. The lancet device can be used to collect a quantity of a biological sample, such as blood from the user. A biological test strip such as glucose strips supported by a strip station can interact with the collected biological sample by electro-chemical or other means. The lancet device and the strip station can be supported by a disposable module. Measuring equipment supported on a reusable module can measure a biological property, such as blood glucose level in milligrams per deciliter. A display monitor supported on the reusable module can display the measured blood glucose level.
- A user can repeat this procedure with a second lancet station and a second strip station included on the disposable module of the biological kit. Once the user has used all the lancet stations and all the strip stations on the disposable module of the biological kit, the user can disengage the disposable module by removing the connection between the disposable module connector and the reusable module connector. The reusable module can be retained by the user and another disposable module comprising lancet devices and strip stations can be removably connected to the reusable module using techniques discussed elsewhere herein.
- Various examples of the invention have been described. Although the present invention has been described in considerable detail with reference to certain disclosed embodiments, the embodiments are presented for purposes of illustration and not limitation. Other embodiments incorporating the invention are possible. One skilled in the art will appreciate that various changes, adaptations, and modifications may be made without departing from the spirit of the invention and the scope of the appended claims.
Claims (2)
1. A lancet device comprising:
(a) a base that includes a support surface;
(b) a lancet supported by the base and extending away from the support surface at an angle of approximately 90°;
(c) a cover that includes (i) a peripheral edge along which the cover is connected to the base, (ii) a cover region configured to cover the lancet when the cover is in an un-depressed position, the cover region having a cover region geometry, (iii) a lancet aperture through which the lancet is configured to protrude when the cover is in a depressed position, and (iv) a peripheral hinge near the peripheral edge, the peripheral hinge having a peripheral hinge geometry that differs from the cover region geometry to facilitate controlled movement of the cover from the un-depressed position to the depressed position upon application of a predetermined depression force.
2-26. (canceled)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18/470,167 US20240000353A1 (en) | 2013-04-29 | 2023-09-19 | Blood glucose management |
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361817172P | 2013-04-29 | 2013-04-29 | |
US13/946,838 US9237866B2 (en) | 2013-04-29 | 2013-07-19 | Blood glucose management |
US201514787725A | 2015-10-28 | 2015-10-28 | |
US14/995,652 US20160120452A1 (en) | 2013-04-29 | 2016-01-14 | Blood glucose management |
US15/786,746 US20180035936A1 (en) | 2013-04-29 | 2017-10-18 | Blood glucose management |
US16/998,157 US20200375517A1 (en) | 2013-04-29 | 2020-08-20 | Blood glucose management |
US18/470,167 US20240000353A1 (en) | 2013-04-29 | 2023-09-19 | Blood glucose management |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/998,157 Continuation US20200375517A1 (en) | 2013-04-29 | 2020-08-20 | Blood glucose management |
Publications (1)
Publication Number | Publication Date |
---|---|
US20240000353A1 true US20240000353A1 (en) | 2024-01-04 |
Family
ID=51789812
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/946,838 Active 2033-10-07 US9237866B2 (en) | 2013-04-29 | 2013-07-19 | Blood glucose management |
US14/787,725 Abandoned US20160100785A1 (en) | 2013-04-29 | 2014-04-25 | Blood glucose management |
US14/995,652 Abandoned US20160120452A1 (en) | 2013-04-29 | 2016-01-14 | Blood glucose management |
US15/786,746 Abandoned US20180035936A1 (en) | 2013-04-29 | 2017-10-18 | Blood glucose management |
US16/998,157 Abandoned US20200375517A1 (en) | 2013-04-29 | 2020-08-20 | Blood glucose management |
US18/470,167 Pending US20240000353A1 (en) | 2013-04-29 | 2023-09-19 | Blood glucose management |
Family Applications Before (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/946,838 Active 2033-10-07 US9237866B2 (en) | 2013-04-29 | 2013-07-19 | Blood glucose management |
US14/787,725 Abandoned US20160100785A1 (en) | 2013-04-29 | 2014-04-25 | Blood glucose management |
US14/995,652 Abandoned US20160120452A1 (en) | 2013-04-29 | 2016-01-14 | Blood glucose management |
US15/786,746 Abandoned US20180035936A1 (en) | 2013-04-29 | 2017-10-18 | Blood glucose management |
US16/998,157 Abandoned US20200375517A1 (en) | 2013-04-29 | 2020-08-20 | Blood glucose management |
Country Status (6)
Country | Link |
---|---|
US (6) | US9237866B2 (en) |
EP (2) | EP3167804B1 (en) |
CN (1) | CN105377136B (en) |
AU (2) | AU2014260194B2 (en) |
CA (1) | CA2909364A1 (en) |
WO (1) | WO2014179171A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9171343B1 (en) | 2012-09-11 | 2015-10-27 | Aseko, Inc. | Means and method for improved glycemic control for diabetic patients |
US9897565B1 (en) | 2012-09-11 | 2018-02-20 | Aseko, Inc. | System and method for optimizing insulin dosages for diabetic subjects |
US9237866B2 (en) * | 2013-04-29 | 2016-01-19 | Birch Narrows Development, LLC | Blood glucose management |
US9486580B2 (en) | 2014-01-31 | 2016-11-08 | Aseko, Inc. | Insulin management |
US9898585B2 (en) | 2014-01-31 | 2018-02-20 | Aseko, Inc. | Method and system for insulin management |
US9892234B2 (en) | 2014-10-27 | 2018-02-13 | Aseko, Inc. | Subcutaneous outpatient management |
US11081226B2 (en) | 2014-10-27 | 2021-08-03 | Aseko, Inc. | Method and controller for administering recommended insulin dosages to a patient |
EP3337402A4 (en) | 2015-08-20 | 2019-04-24 | Aseko, Inc. | Diabetes management therapy advisor |
WO2017040352A1 (en) * | 2015-08-28 | 2017-03-09 | Pops! Diabetes Care, Inc. | Blood glucose management system |
US11166658B2 (en) * | 2016-07-28 | 2021-11-09 | Invitae Corporation | Blood sampling system and method |
KR20240036152A (en) * | 2017-01-10 | 2024-03-19 | 드로브릿지 헬스, 인크. | Devices, systems, and methods for sample collection |
EP3695420A1 (en) | 2017-10-10 | 2020-08-19 | POPS! Diabetes Care, Inc. | Physiological condition information for remote healthcare determination |
CN108324253B (en) * | 2018-03-28 | 2021-01-22 | 佳木斯大学 | Simple touch perception diagnosis and treatment device for neurology department |
US20220369962A1 (en) * | 2019-10-29 | 2022-11-24 | Jiaxing Summed Medtech Co., Ltd. | A blood glucose monitoring device and system |
Family Cites Families (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8401536A (en) | 1984-05-11 | 1985-12-02 | Medscan B V I O | BLOOD SAMPLING UNIT. |
US5014718A (en) | 1988-01-22 | 1991-05-14 | Safety Diagnostics, Inc. | Blood collection and testing method |
US5070886A (en) | 1988-01-22 | 1991-12-10 | Safety Diagnostice, Inc. | Blood collection and testing means |
US5054499A (en) | 1989-03-27 | 1991-10-08 | Swierczek Remi D | Disposable skin perforator and blood testing device |
US5139029A (en) | 1990-04-06 | 1992-08-18 | Henry Fishman | Allergy testing apparatus and method |
DK120991D0 (en) | 1991-06-21 | 1991-06-21 | Novo Nordisk As | BLOOD SAMPLES |
US5402798A (en) | 1991-07-18 | 1995-04-04 | Swierczek; Remi | Disposable skin perforator and blood testing device |
DE69229180T2 (en) | 1991-11-12 | 1999-10-14 | Urs. A. Ramel | LANCETTE DEVICE |
US5231993A (en) | 1991-11-20 | 1993-08-03 | Habley Medical Technology Corporation | Blood sampler and component tester with guide member |
US5324302A (en) | 1992-10-13 | 1994-06-28 | Sherwood Medical Company | Lancet with locking cover |
CA2079192C (en) | 1992-09-25 | 1995-12-26 | Bernard Strong | Combined lancet and multi-function cap and lancet injector for use therewith |
HU219921B (en) | 1993-10-20 | 2001-09-28 | Ervin Lipscher | Device for making blood test, especially from fingers |
US5529581A (en) | 1994-05-17 | 1996-06-25 | International Technidyne Corporation | Lancet device for creating a skin incision |
IE72524B1 (en) | 1994-11-04 | 1997-04-23 | Elan Med Tech | Analyte-controlled liquid delivery device and analyte monitor |
US5636640A (en) | 1995-02-06 | 1997-06-10 | Volunteers For Medical Engineering | Liquid sampling and test apparatus |
US5709699A (en) | 1995-09-01 | 1998-01-20 | Biosafe Diagnostics Corporation | Blood collection and testing device |
US6196747B1 (en) * | 1995-12-21 | 2001-03-06 | Creative Packaging Corp. | Product dispensing cover |
US5630828A (en) | 1996-04-17 | 1997-05-20 | International Techndyne Corporation | Low cost disposable lancet |
US6299626B1 (en) | 1997-06-02 | 2001-10-09 | Paul Viranyi | Skin pricker |
US6071294A (en) | 1997-12-04 | 2000-06-06 | Agilent Technologies, Inc. | Lancet cartridge for sampling blood |
US6036924A (en) | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
US5971941A (en) | 1997-12-04 | 1999-10-26 | Hewlett-Packard Company | Integrated system and method for sampling blood and analysis |
US6302855B1 (en) * | 1998-05-20 | 2001-10-16 | Novo Nordisk A/S | Medical apparatus for use by a patient for medical self treatment of diabetes |
US6540672B1 (en) * | 1998-12-09 | 2003-04-01 | Novo Nordisk A/S | Medical system and a method of controlling the system for use by a patient for medical self treatment |
US6132449A (en) | 1999-03-08 | 2000-10-17 | Agilent Technologies, Inc. | Extraction and transportation of blood for analysis |
US6228100B1 (en) | 1999-10-25 | 2001-05-08 | Steven Schraga | Multi-use lancet device |
DE60018796T2 (en) | 1999-12-16 | 2006-04-13 | Alza Corp., Mountain View | DEVICE FOR INCREASING THE TRANSDERMAL FLOW OF SAMPLE MATERIALS |
US6706159B2 (en) | 2000-03-02 | 2004-03-16 | Diabetes Diagnostics | Combined lancet and electrochemical analyte-testing apparatus |
DE10010694A1 (en) | 2000-03-04 | 2001-09-06 | Roche Diagnostics Gmbh | Lancet including tipped needle with body surrounding tip |
DE10026172A1 (en) | 2000-05-26 | 2001-11-29 | Roche Diagnostics Gmbh | Body fluid withdrawal system |
DE10026170A1 (en) | 2000-05-26 | 2001-12-06 | Roche Diagnostics Gmbh | Body fluid withdrawal system |
WO2002015778A1 (en) * | 2000-08-18 | 2002-02-28 | Cygnus, Inc. | Analyte monitoring device alarm augmentation system |
US20020087180A1 (en) | 2000-12-29 | 2002-07-04 | Searle Stephen D. | Blood lancet |
ATE493929T1 (en) | 2001-03-29 | 2011-01-15 | Lifescan Scotland Ltd | INTEGRATED BLOOD SAMPLE METER WITH TEST STRIPS |
US6591124B2 (en) | 2001-05-11 | 2003-07-08 | The Procter & Gamble Company | Portable interstitial fluid monitoring system |
WO2002100253A2 (en) | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Blood sampling device with diaphragm actuated lancet |
EP1406537B1 (en) | 2001-06-12 | 2011-01-12 | Pelikan Technologies Inc. | Integrated blood sampling analysis system with multi-use sampling module |
DE10142232B4 (en) | 2001-08-29 | 2021-04-29 | Roche Diabetes Care Gmbh | Process for the production of an analytical aid with a lancet and test element |
DE20213607U1 (en) | 2002-02-21 | 2003-07-03 | Paul Hartmann AG, 89522 Heidenheim | Blood analyzer for the determination of an analyte |
US20040010207A1 (en) * | 2002-07-15 | 2004-01-15 | Flaherty J. Christopher | Self-contained, automatic transcutaneous physiologic sensing system |
TR200301291A2 (en) * | 2002-08-20 | 2004-02-23 | Dart Industries Inc. | Adjustable mold for forming shaped foodstuffs |
AU2003269844A1 (en) | 2002-10-07 | 2004-04-23 | Novo Nordisk A/S | Needle device comprising a plurality of needles |
US20060184189A1 (en) | 2002-11-15 | 2006-08-17 | Lorin Olson | Cap for a dermal tissue lancing device |
AU2003280756A1 (en) | 2002-11-15 | 2004-06-15 | Arkray, Inc. | Lancet and needle insertion device |
US7374949B2 (en) | 2003-05-29 | 2008-05-20 | Bayer Healthcare Llc | Diagnostic test strip for collecting and detecting an analyte in a fluid sample |
EP1621132B1 (en) | 2003-06-27 | 2007-03-07 | Ehrfeld Mikrotechnik AG in Insolvenz | Device and method for sampling and analysing body fluids |
EP1522260A1 (en) * | 2003-06-27 | 2005-04-13 | Ehrfeld Mikrotechnik AG | Device for blood sampling and simultaneous quantitative determination of blood analytes |
US20050085840A1 (en) | 2003-10-15 | 2005-04-21 | Surgilance Pte Ltd | Lancet assembly |
US8221332B2 (en) | 2003-11-12 | 2012-07-17 | Facet Technologies, Llc | Multi-lancet cartridge and lancing device |
US20050234491A1 (en) | 2004-04-16 | 2005-10-20 | Allen John J | Method for lancing a dermal tissue target site employing a dermal tissue lancing device with a tiltable cap |
US8591436B2 (en) | 2004-04-30 | 2013-11-26 | Roche Diagnostics Operations, Inc. | Lancets for bodily fluid sampling supplied on a tape |
US9101302B2 (en) | 2004-05-03 | 2015-08-11 | Abbott Diabetes Care Inc. | Analyte test device |
US8211038B2 (en) | 2004-09-17 | 2012-07-03 | Abbott Diabetes Care Inc. | Multiple-biosensor article |
DE102004058164B4 (en) | 2004-12-02 | 2009-04-16 | Roche Diagnostics Gmbh | Lancing device for taking blood and method for the preparation thereof |
US8211036B2 (en) | 2005-05-27 | 2012-07-03 | Stat Medical Devices, Inc. | Disposable lancet device cap with integral lancet and/or test strip and testing device utilizing the cap |
PL376767A1 (en) | 2005-08-25 | 2007-03-05 | Htl-Strefa Spółka Z Ograniczoną Odpowiedzialnością | Apparatus for patient's skin punctures |
US8469984B2 (en) | 2005-10-25 | 2013-06-25 | Bayer Healthcare Llc | Single use lancing device |
EP1785730B1 (en) | 2005-11-15 | 2013-02-13 | F. Hoffmann-La Roche AG | System and method for examining a liquid sample |
US20070112281A1 (en) | 2005-11-17 | 2007-05-17 | Olson Lorin P | Cap with revolving body for a dermal tissue lancing device |
US20070129620A1 (en) | 2005-12-02 | 2007-06-07 | Peter Krulevitch | Selectively exposable miniature probes with integrated sensor arrays for continuous in vivo diagnostics |
US8333712B2 (en) | 2006-01-11 | 2012-12-18 | Canon Kabushiki Kaisha | Body fluid sampling device |
EP1878386A1 (en) | 2006-07-15 | 2008-01-16 | Roche Diagnostics GmbH | Process to produce lancet; lancet, lancet band and device for pricking the skin |
GB2440119A (en) | 2006-07-18 | 2008-01-23 | Owen Mumford Ltd | Skin Pricking Device |
EP1880671B1 (en) | 2006-07-18 | 2010-09-08 | Roche Diagnostics GmbH | Lancet wheel |
EP1887355B1 (en) | 2006-08-02 | 2017-09-27 | F. Hoffmann-La Roche AG | Coating method for a microfluidic system. |
US7846110B2 (en) | 2006-08-03 | 2010-12-07 | Advanced Medical Products Gmbh | Self-contained test unit for testing body fluids |
US20080058726A1 (en) | 2006-08-30 | 2008-03-06 | Arvind Jina | Methods and Apparatus Incorporating a Surface Penetration Device |
EP1992284A1 (en) | 2007-05-15 | 2008-11-19 | F.Hoffmann-La Roche Ag | Method for storing piecing elements and belt magazine |
JP4891276B2 (en) | 2007-08-23 | 2012-03-07 | テルモ株式会社 | Puncture device |
US20090099427A1 (en) | 2007-10-12 | 2009-04-16 | Arkal Medical, Inc. | Microneedle array with diverse needle configurations |
US20090204027A1 (en) | 2008-02-11 | 2009-08-13 | Zuk Robert F | Lancet with shielded lance |
EP2265324B1 (en) | 2008-04-11 | 2015-01-28 | Sanofi-Aventis Deutschland GmbH | Integrated analyte measurement system |
EP2181651A1 (en) | 2008-10-29 | 2010-05-05 | Roche Diagnostics GmbH | Instrument and system for producing a sample of a body liquid and for analysis thereof |
JP5486183B2 (en) | 2008-12-08 | 2014-05-07 | テルモ株式会社 | Puncture device |
ES2483741T3 (en) | 2009-07-30 | 2014-08-07 | Becton, Dickinson And Company | Lancet device that has a saddle-shaped tip |
KR20110017063A (en) | 2009-08-13 | 2011-02-21 | (주)마이티시스템 | Lancet block and lancet device |
TWI527565B (en) * | 2010-07-08 | 2016-04-01 | 賽諾菲阿凡提斯德意志有限公司 | Allowing measurements to be made of a blood sample |
US8808202B2 (en) | 2010-11-09 | 2014-08-19 | Seventh Sense Biosystems, Inc. | Systems and interfaces for blood sampling |
US8647357B2 (en) | 2011-02-05 | 2014-02-11 | Birch Narrows Development Llc | Lancet device with flexible cover |
WO2012119128A1 (en) * | 2011-03-02 | 2012-09-07 | Massachusetts Institute Of Technology | Multiplexed diagnostic systems |
US20120330119A1 (en) * | 2011-06-21 | 2012-12-27 | Gadlight, Inc. | Analyte Testing Device with Lancet Cartridge and Test Strip Cartridge |
US9642563B2 (en) * | 2012-12-18 | 2017-05-09 | Crawford Capital Investments, Llc | Glucose monitoring device in a protective smartphone case |
US9237866B2 (en) * | 2013-04-29 | 2016-01-19 | Birch Narrows Development, LLC | Blood glucose management |
-
2013
- 2013-07-19 US US13/946,838 patent/US9237866B2/en active Active
-
2014
- 2014-04-25 EP EP16207531.1A patent/EP3167804B1/en active Active
- 2014-04-25 CN CN201480035800.5A patent/CN105377136B/en active Active
- 2014-04-25 US US14/787,725 patent/US20160100785A1/en not_active Abandoned
- 2014-04-25 WO PCT/US2014/035507 patent/WO2014179171A1/en active Application Filing
- 2014-04-25 EP EP14726304.0A patent/EP2991553B1/en active Active
- 2014-04-25 AU AU2014260194A patent/AU2014260194B2/en active Active
- 2014-04-25 CA CA2909364A patent/CA2909364A1/en not_active Abandoned
-
2016
- 2016-01-14 US US14/995,652 patent/US20160120452A1/en not_active Abandoned
-
2017
- 2017-10-18 US US15/786,746 patent/US20180035936A1/en not_active Abandoned
-
2018
- 2018-10-30 AU AU2018256521A patent/AU2018256521B2/en active Active
-
2020
- 2020-08-20 US US16/998,157 patent/US20200375517A1/en not_active Abandoned
-
2023
- 2023-09-19 US US18/470,167 patent/US20240000353A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2014179171A1 (en) | 2014-11-06 |
EP3167804B1 (en) | 2018-10-24 |
US20160120452A1 (en) | 2016-05-05 |
AU2018256521A1 (en) | 2018-11-22 |
US20180035936A1 (en) | 2018-02-08 |
US9237866B2 (en) | 2016-01-19 |
AU2014260194B2 (en) | 2018-11-22 |
US20160100785A1 (en) | 2016-04-14 |
US20200375517A1 (en) | 2020-12-03 |
EP3167804A1 (en) | 2017-05-17 |
CN105377136B (en) | 2018-02-16 |
AU2018256521B2 (en) | 2019-01-03 |
EP2991553A1 (en) | 2016-03-09 |
CN105377136A (en) | 2016-03-02 |
CA2909364A1 (en) | 2014-11-06 |
EP2991553B1 (en) | 2017-02-15 |
AU2014260194A1 (en) | 2015-12-10 |
US20140323915A1 (en) | 2014-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20240000353A1 (en) | Blood glucose management | |
US10945649B2 (en) | Medical device inserters and processes of inserting and using medical devices | |
CN101036581B (en) | Micropore forming system | |
RU2766749C2 (en) | Continuous glucose monitoring system and method | |
EP2992827A1 (en) | Systems and interfaces for blood sampling | |
EP2184694A3 (en) | Communication medium for diabetes management | |
WO2012154362A1 (en) | Devices and methods for delivery and/or withdrawal of fluids and preservation of withdrawn fluids | |
AU2011230596A1 (en) | Medical device inserters and processes of inserting and using medical devices | |
EP2239000A2 (en) | System for measuring components in a living body, kit for a micropore forming device, and marking member | |
KR20190027240A (en) | Diagnostic strip with integrated lancet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: POPS! DIABETES CARE, INC., MINNESOTA Free format text: MERGER AND CHANGE OF NAME;ASSIGNORS:BIRCH NARROWS DEVELOPMENT LLC;POPS! DIABETES CARE, INC.;REEL/FRAME:066375/0655 Effective date: 20151230 Owner name: BIRCH NARROWS DEVELOPMENT LLC, MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CHRISTENSEN, CURTIS;DAVIS, DANIEL;DAVIS, ERIK;SIGNING DATES FROM 20130708 TO 20130709;REEL/FRAME:066375/0649 |